No definition available.
Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)
C3_BREAST_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
4 out of 7 registries used, show all original rules. |
24978 |
4. Check minimum number of eventsNone |
24978 |
5. Include endpointsNone |
24978 |
6. Filter based on genotype QC (FinnGen only) |
24978 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
- Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of breast
- Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of breast, HER-positive
- Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24978 | 24978 | - |
| Unadjusted period prevalence (%) | 8.51 | 8.51 | - |
| Median age at first event (years) | 59.60 | 59.60 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 10569
- Matched controls
- 84772
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WF049
NOMESCO Finland
Radiotherapy of metastasis
3678.7
323.0
448
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
323.0
345
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
22.9
323.0
990
380
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
62.5
323.0
469
63
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
191.4
323.0
629
28
ZX090
NOMESCO Finland
Other technic of radiotherapy
794.2
323.0
1070
12
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
323.0
773
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
682.6
323.0
1209
16
115
Kela drug reimbursment
Breast cancer
+∞
323.0
8293
*
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.6
323.0
1377
1892
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.3
323.0
5606
14921
X76
ICPC
Malignant neoplasm breast female
11839.4
323.0
1305
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
323.0
512
*
L02BG04
ATC
letrozole; oral
142.5
323.0
4158
384
A04AD12
ATC
aprepitant; systemic
1140.8
323.0
1255
10
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
3923.5
323.0
476
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
323.0
414
*
R4110
NOMESCO Finland
Physiotherapy
3.4
323.0
3739
11735
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
323.0
344
*
JN4AD
NOMESCO Finland
Body CT examination
11.6
323.0
852
637
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.8
323.0
5535
15849
ZX120
NOMESCO Finland
Intravenous
6.3
323.0
1640
2404
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1163.0
323.0
547
*
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
39.2
323.0
587
127
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
323.0
340
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
447.1
323.0
1409
29
HA1AA
NOMESCO Finland
X-ray mammography
51.9
323.0
4847
1361
HAC20
NOMESCO Finland
Total mastectomy
1679.5
323.0
3313
23
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
67.9
323.0
1798
255
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
10790.0
323.0
1203
*
Z51.0
ICD-10 Finland
Radiotherapy session
1533.2
323.0
385
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
310.6
323.0
412
11
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
39.8
323.0
1332
306
ZZR10
NOMESCO Finland
Flap of skin and muscle
163.3
323.0
486
25
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
323.0
362
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
323.0
665
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
92.8
323.0
2289
252
A03FA01
ATC
metoclopramide; systemic, rectal
12.9
323.0
6007
7858
A04AA55
ATC
palonosetron, combinations; systemic
13983.2
323.0
2645
*
L02BG06
ATC
exemestane; oral
+∞
323.0
980
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
323.0
1114
*
1CD02
NOMESCO Finland
NA
+∞
323.0
531
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
323.0
1312
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
323.0
635
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
323.0
773
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
2204.7
323.0
1482
6
WZC30
NOMESCO Finland
Teaching
5.8
323.0
2252
3773
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
7.8
323.0
833
922
TQW20
NOMESCO Finland
Tatoe
401.8
323.0
1085
24
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
323.0
2035
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
6183.1
323.0
4002
8
NK6AN
NOMESCO Finland
Total body bone isotope imaging
292.6
323.0
1044
32
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
515.2
323.0
1448
26
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
323.0
356
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
49.1
323.0
480
82
HAE99
NOMESCO Finland
Other reconstruction of breast
75.8
323.0
547
61
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
323.0
1058
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
789.8
323.0
1802
22
JN4BD
NOMESCO Finland
Extensive body CT
14.4
323.0
1686
1106
XX3DW
NOMESCO Finland
Time consuming IT work
23.3
323.0
3186
1540
B01AB05
ATC
enoxaparin; parenteral
2.5
323.0
3287
12773
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
785.8
323.0
2708
37
L02BG03
ATC
anastrozole; oral
873.5
323.0
712
7
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
323.0
3630
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
323.0
1851
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
323.0
354
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
323.0
1010
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
8099.9
323.0
931
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.7
323.0
1672
1787
XX1XN
NOMESCO Finland
Other isotope examination
5657.3
323.0
670
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
323.0
945
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
6434.5
323.0
2966
5
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
323.0
455
*
C50
ICD-10 Finland
Malignant neoplasm of breast
4616.4
323.0
1513
*
L03AA13
ATC
pegfilgrastim; parenteral
7974.9
323.0
2359
*
L02BA01
ATC
tamoxifen; oral
1866.1
323.0
3757
25
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
323.0
1173
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
14325.2
323.0
1538
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
214.3
323.0
361
14
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
292.4
323.0
389
11
A04AA01
ATC
ondansetron; systemic, rectal
13.7
323.0
1502
1011
ZX080
NOMESCO Finland
Image guided radiotherapy
1270.1
323.0
1126
8
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
136.7
323.0
833
53
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
323.0
936
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
72.2
323.0
1112
138
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
4503599627370496.0
323.0
4973
*
ZX112
NOMESCO Finland
Subcutaneous
23.1
323.0
557
204
C50.99
ICD-10 Finland
Breast, unspecified
6052.6
323.0
1895
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
323.0
851
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
1021.0
323.0
1238
11
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.8
323.0
4183
10200
L01BC06
ATC
capecitabine; oral
+∞
323.0
851
*
WX402
NOMESCO Finland
General anaesthesia
4.2
323.0
2777
6670
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4075.8
323.0
2739
7
A04AA02
ATC
granisetron; systemic, transdermal
811.8
323.0
2774
37
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
7888.9
323.0
909
*
H02AB02
ATC
dexamethasone; systemic
220.8
323.0
5319
387
WF002
NOMESCO Finland
Radical radiotherapy
70.3
323.0
413
49
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
3888.4
323.0
472
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
323.0
513
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
110.1
323.0
705
55
L03AA02
ATC
filgrastim; parenteral
233.2
323.0
576
21
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.4
323.0
1136
656
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
152.7
323.0
1347
81
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
1406.6
323.0
1081
7
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
39.1
323.0
4432
1539
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
408.0
323.0
670
14
HAB40
NOMESCO Finland
Wedge excision of mammary gland
258.9
323.0
3809
184
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
458.9
323.0
647
12
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
323.0
3691
*
Z31.5
ICD-10 Finland
Genetic counselling
8.2
323.0
1724
1971
PJA12
NOMESCO Finland
Sentinel node biopsy
6509.5
323.0
6733
26
ZZF00
NOMESCO Finland
Graft of adipose tissue
44.2
323.0
544
104
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
13361.1
323.0
2556
*
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
96.4
323.0
493
43
HAB99
NOMESCO Finland
Other partial excision of mammary gland
31.8
323.0
1269
362
N63
ICD-10 Finland
Unspecified lump in breast
4.7
323.0
1516
2896
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
323.0
402
*
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
67.3
317.7
396
49
TQB05
NOMESCO Finland
Puncture of skin of trunk
38.4
311.9
428
93
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
22.6
306.1
480
178
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
383.8
299.7
326
7
1501
Kela drug reimbursment
Palbociclib
+∞
290.1
302
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
290.1
302
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
1242.8
279.8
296
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
278.5
290
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
355.7
277.7
303
7
M05BX04
ATC
denosumab; parenteral
7.7
269.4
691
767
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
52.2
267.9
347
55
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
267.4
1052
1999
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
266.0
277
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
262.7
3848
17557
N02BE01
ATC
paracetamol; systemic, rectal
2.7
262.7
9391
63297
394
Kela drug reimbursment
Palbociclib
+∞
260.2
271
*
HAD99
NOMESCO Finland
Other plastic operation on breast
39.5
258.9
353
74
ZXA05
NOMESCO Finland
Left side
2.4
258.7
2843
11279
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
329.0
256.7
281
7
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
33.5
252.0
356
88
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
446.4
251.3
272
5
L02BA03
ATC
fulvestrant; parenteral
+∞
249.6
260
*
PJW99
NOMESCO Finland
Other operation on lymphatic system
728.4
249.0
266
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
248.6
259
*
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
228.9
248.5
277
10
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
252.3
247.1
274
9
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
245.7
256
*
192
Kela drug reimbursment
Fulvestrant
+∞
242.8
253
*
ZXA00
NOMESCO Finland
Right side
2.3
242.5
2937
12162
1XC03
NOMESCO Finland
NA
+∞
238.0
248
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
198.1
235.8
265
11
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
414.3
233.1
253
5
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
231.3
241
*
WX702
NOMESCO Finland
Supraglottic ventilation device
4.2
227.8
985
2040
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
26.1
224.1
337
107
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
967.1
222.1
236
*
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
29.8
221.1
321
89
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
49.8
217.5
284
47
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
215.8
225
*
HAD40
NOMESCO Finland
Mastopexy
28.8
214.4
314
90
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
212.9
222
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
211.0
220
*
L01XE33
ATC
[U] palbociclib; oral
+∞
210.1
219
*
A79
ICPC
Malignancy NOS
240.1
209.5
233
8
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
207.7
203.4
228
9
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
15.2
203.3
365
199
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
203.3
212
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
75.4
202.1
248
27
130
Kela drug reimbursment
Malignant tumour
+∞
201.4
210
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
198.6
2863
12622
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
198.5
207
*
Z51.5
ICD-10 Finland
Palliative care
13.6
198.3
372
226
A02BC02
ATC
pantoprazole; systemic
1.9
195.2
7016
43357
JN4CD
NOMESCO Finland
Very extensive body CT
11.0
193.8
402
304
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
193.7
202
*
HA1HA
NOMESCO Finland
Tomosynthesis mammography
39.0
191.1
261
55
L02AE02
ATC
leuprorelin; implant, parenteral
7.4
191.0
499
565
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
190.8
199
*
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
58.5
190.3
242
34
B01AB10
ATC
tinzaparin; parenteral
4.4
189.4
765
1475
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
417.7
188.9
205
*
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
53.7
183.2
236
36
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
+∞
183.1
191
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
180.2
188
*
L02AE03
ATC
goserelin; implant
8.8
180.2
420
395
R50.9
ICD-10 Finland
Fever, unspecified
2.7
179.9
1415
4558
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
178.3
186
*
XX1AD
NOMESCO Finland
Other CT-examination
521.6
178.1
192
*
N02AA05
ATC
oxycodone; systemic
3.0
174.8
1139
3245
HAC25
NOMESCO Finland
Radical mastectomy
+∞
174.4
182
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
174.4
182
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
1428.8
173.2
183
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
1420.5
172.2
182
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
502.1
171.4
185
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
170.6
178
*
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
9.2
170.0
387
349
L01CA04
ATC
vinorelbine; systemic
+∞
167.7
175
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
367.7
166.0
181
*
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
95.2
165.9
198
17
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
165.8
173
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
295.2
165.4
182
5
L01EF01
ATC
palbociclib; oral
+∞
159.1
166
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
158.1
165
*
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
340.7
153.6
168
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
151.4
158
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
51.1
149.5
194
31
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
149.4
156
*
HA1BA
NOMESCO Finland
Extensive X-ray mammography
32.2
147.0
209
53
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
5.7
146.4
460
668
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
144.6
151
*
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
61.6
143.6
181
24
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
254.1
139.8
155
5
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
12.4
139.5
272
180
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
4.2
137.6
580
1158
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
27.2
136.9
203
61
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
136.0
142
*
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
21.5
134.4
213
81
HA1SA
NOMESCO Finland
Expansion mammography
47.8
134.1
176
30
N06AX16
ATC
venlafaxine; oral
2.0
130.6
1975
8646
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.4
128.7
641
11656
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
3.3
128.5
729
1866
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
42.2
127.4
171
33
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
+∞
124.5
130
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
123.6
1223
4412
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
123.5
129
*
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
+∞
120.6
126
*
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
+∞
120.6
126
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
120.5
729
1954
X21
ICPC
Breast sympt/compl female other
5.4
120.2
396
608
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
54.0
119.1
153
23
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
114.5
730
2027
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.3
112.3
292
327
A46
ICD-10 Finland
Erysipelas
2.4
109.1
1077
3865
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
114.5
108.5
127
9
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
25.7
107.2
161
51
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
9.6
105.3
232
197
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
+∞
104.3
109
*
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
22.0
103.2
162
60
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
102.4
107
*
TQW99
NOMESCO Finland
Other minor procedure on skin
4.0
101.2
440
901
X19
ICPC
Breast lump/mass female
5.5
98.9
317
471
3AA13
NOMESCO Finland
NA
+∞
96.7
101
*
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
+∞
95.7
100
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
95.7
100
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
415.7
94.9
103
*
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
54.4
94.5
121
18
S18
ICPC
Laceration/cut
1.6
94.2
3344
18930
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
93.8
98
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
92.8
97
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
92.8
97
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
99.0
92.7
110
9
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
10.7
92.7
193
147
ZSZ10
NOMESCO Finland
Secondary repair operation
107.3
90.1
106
8
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
767.9
89.0
95
*
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
+∞
87.1
91
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
87.1
91
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.2
86.6
291
457
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
735.2
85.2
91
*
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
+∞
85.2
89
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
84.8
1676
7951
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
47.3
84.7
111
19
D05.0
ICD-10 Finland
Lobular carcinoma in situ
114.5
84.7
99
7
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
+∞
84.2
88
*
QBJ00
NOMESCO Finland
Liposuction in trunk
8.8
82.5
190
175
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
81.3
85
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
80.9
398
907
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
+∞
80.4
84
*
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
+∞
80.4
84
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.4
78.4
307
568
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
177.9
77.9
88
*
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
+∞
77.5
81
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
76.5
80
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
8.7
76.1
177
166
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
333.9
75.9
83
*
J01MA12
ATC
levofloxacin; systemic
1.8
75.6
1485
7005
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
13.8
75.2
139
82
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
645.5
74.7
80
*
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
+∞
74.6
78
*
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
29.6
73.5
106
29
WW500
NOMESCO Finland
Blood transfusion
5.0
73.1
255
418
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
+∞
72.7
76
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
+∞
70.8
74
*
XX9TE
NOMESCO Finland
Compementary ultrasound examination
9.6
70.7
155
131
M05BA02
ATC
clodronic acid; systemic
129.3
69.3
80
5
HAD20
NOMESCO Finland
Liposuction of breast
31.7
69.1
98
25
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
+∞
68.9
72
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
68.8
578
1890
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
33.7
68.7
96
23
JN6AD
NOMESCO Finland
CT of torso and neck
18.3
68.2
113
50
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
68.2
526
1638
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
68.0
812
3159
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
8.3
67.5
161
158
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
+∞
66.0
69
*
HAD00
NOMESCO Finland
Augmentation mammoplasty
30.4
65.7
94
25
ZSZ00
NOMESCO Finland
Primary repair operation
196.4
65.1
73
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
45.8
64.7
85
15
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
18.7
64.4
106
46
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
22.9
64.2
99
35
ZZR00
NOMESCO Finland
Flap of skin
9.5
64.1
141
120
X26
ICPC
Fear of breast cancer female
9.9
64.1
138
113
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
34.2
63.9
89
21
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
11.9
63.6
125
85
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
547.8
63.2
68
*
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
63.1
66
*
128
Kela drug reimbursment
Cancers of female genital organs
276.7
62.7
69
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
61.6
1318
6358
1XC13
NOMESCO Finland
NA
+∞
60.2
63
*
HA1AE
SPAT
NA
3.1
58.4
355
949
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
174.8
57.6
65
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.4
56.7
300
725
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
+∞
56.4
59
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
56.4
59
*
HA1S1
NOMESCO Finland
Photography of breasts
90.1
56.1
67
6
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.5
56.0
157
197
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
482.8
55.6
60
*
SPAT1269
SPAT
Other puncture and/or drainage
12.4
54.0
104
68
9703
FHL
Breast resection
11.2
54.0
109
79
HA1DA
NOMESCO Finland
Restricted mammography
50.6
53.5
69
11
WB321
NOMESCO Finland
Multiple adjuvant therapy of malignancy with biomodifiers
+∞
52.6
55
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
52.0
579
2177
WX110
NOMESCO Finland
Local anesthesy
1.4
52.0
6815
48094
SPAT1152
SPAT
Removal of foreign body from under the skin
3.6
51.9
254
577
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
21.5
51.1
80
30
SPAT1324
SPAT
Screening procedure
0.7
50.4
2204
23366
N05CF01
ATC
zopiclone; oral
1.4
50.2
2862
17434
D70.89
ICD-10 Finland
Neutropenic splenomegaly
6.4
49.8
140
177
GD1AD
NOMESCO Finland
Thorax CT examination
3.3
49.8
272
674
156
Kela drug reimbursment
Lapatinib
+∞
49.7
52
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
62.6
49.7
62
8
J01DB01
ATC
cefalexin; oral
1.4
49.7
8164
59667
WX704
NOMESCO Finland
Intubation
2.0
48.9
662
2705
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
48.8
51
*
Z31.6
ICD-10 Finland
General counselling and advice on procreation
7.8
48.7
120
125
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
218.3
48.5
54
*
9706
FHL
Ablation mammae, includes axillary exploration
417.8
48.0
52
*
L01XE07
ATC
[U] lapatinib; oral
+∞
47.8
50
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
37.4
47.8
65
14
OAA41
NOMESCO Finland
Health check based on individual needs
53.7
47.1
60
9
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
+∞
46.8
49
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.7
46.7
107
99
HA1AA
SPAT
NA
4.8
46.6
168
287
D24
ICD-10 Finland
Benign neoplasm of breast
2.9
46.1
309
882
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
17.8
45.1
75
34
HAA10
NOMESCO Finland
Biopsy of mammary gland
5.3
45.0
147
225
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
44.9
47
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
7.0
44.9
118
136
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
44.0
46
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
44.0
46
*
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
+∞
44.0
46
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.6
43.9
164
291
SPAT1153
SPAT
Removal of sutures
1.4
43.7
2308
13789
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.7
43.3
205
454
L02BA02
ATC
toremifene; oral
+∞
43.0
45
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
42.3
578
2367
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
42.2
571
2328
B29
ICPC
Lymph/immune mech sympt/complt other
11.4
41.7
83
59
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
361.0
41.4
45
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
14.1
41.4
75
43
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.2
41.3
168
325
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
41.1
43
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
41.1
43
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.1
41.0
171
339
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
40.1
42
*
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
123.5
39.9
46
*
ZZS55
NOMESCO Finland
Distension of tissue expander
123.5
39.9
46
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
39.2
41
*
8510/3-C50.9
ICD-O-3
Medullary carcinoma, NOS, of breast, NOS
+∞
39.2
41
*
XX2ET
NOMESCO Finland
NA
+∞
39.2
41
*
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
+∞
39.2
41
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
11.1
38.3
77
56
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.2
37.9
76
55
XX2VW
NOMESCO Finland
Radiologic consultation
8.0
37.8
91
92
N62
ICD-10 Finland
Hypertrophy of breast
1.9
37.5
603
2624
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
37.3
448
1739
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
37.3
39
*
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
+∞
37.3
39
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
36.3
38
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
36.3
896
4466
N64.9
ICD-10 Finland
Disorder of breast, unspecified
3.7
35.9
165
357
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
35.5
598
2645
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
+∞
35.4
37
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
35.4
37
*
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
46.3
35.4
46
8
QBA00
NOMESCO Finland
Puncture of skin of trunk
10.8
35.3
72
54
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.8
35.3
125
211
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.3
35.1
364
1322
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.2
34.6
376
1397
ZX050
NOMESCO Finland
Stereotactic radiotherapy
22.5
34.5
53
19
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
156.9
34.5
39
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
34.4
36
*
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
+∞
34.4
36
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
34.4
36
*
PJ5YQ
NOMESCO Finland
NA
+∞
34.4
36
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
34.4
36
*
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
+∞
34.4
36
*
5702
FHL
Local lymph node removal (eg armpit, groin)
34.4
34.1
47
11
HA1RA
SPAT
NA
2.4
33.7
296
992
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
33.6
9483
72460
A21
ICPC
Risk factor for malignancy
152.9
33.5
38
*
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
+∞
33.5
35
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
33.5
35
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
32.5
735
3570
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
+∞
32.5
34
*
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
+∞
32.5
34
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
32.5
467
1950
QCJ00
NOMESCO Finland
Liposuction in upper limb
35.4
32.2
44
10
TPX15
NOMESCO Finland
Removal of vascular injection port
16.7
32.0
54
26
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
17.5
31.3
52
24
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.8
31.3
139
293
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.0
31.1
194
530
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
41.2
30.9
41
8
N64.5
ICD-10 Finland
Other signs and symptoms in breast
2.4
30.8
277
939
J94.8
ICD-10 Finland
Other specified pleural conditions
6.0
30.7
89
119
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
+∞
30.6
32
*
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
+∞
30.6
32
*
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
74.5
30.6
37
*
WF099
NOMESCO Finland
Other radiotherapy
10.9
30.3
61
45
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.8
29.9
204
590
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
29.7
727
3610
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
15.8
29.7
51
26
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
29.6
3051
20097
1515
Kela drug reimbursment
NA
+∞
29.6
31
*
3030
Kela drug reimbursment
Abemaciclib
+∞
29.6
31
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
29.4
595
2796
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
17.6
29.0
48
22
JN5AN
NOMESCO Finland
Total body isotope imaging
132.7
28.9
33
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
58.0
28.8
36
5
A06AH03
ATC
naloxegol; oral
9.8
28.8
61
50
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
+∞
28.7
30
*
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
4.1
28.7
117
229
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.7
28.5
1049
11636
N61
ICD-10 Finland
Inflammatory disorders of breast
2.3
28.4
272
953
RD211
NOMESCO Finland
NA
2.0
28.4
398
1647
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
17.2
28.3
47
22
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
28.2
4185
38395
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
48.3
28.0
36
6
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.9
27.8
96
159
1741A
ICD-9 Finland
Malignant neoplasm of female breast, Central portion
+∞
27.7
29
*
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
+∞
27.7
29
*
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
+∞
27.7
29
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
27.7
29
*
8507/3-C50.4
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast
+∞
27.7
29
*
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
+∞
27.7
29
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
27.5
601
2889
A04AA03
ATC
tropisetron; systemic
26.8
27.5
40
12
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
28.5
27.2
39
11
ZX121
NOMESCO Finland
Central venous catheter
17.3
27.1
45
21
N60.8
ICD-10 Finland
Other benign mammary dysplasias
6.4
27.0
75
95
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
5.1
27.0
89
140
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
85.8
26.9
32
*
KMAK
NOMESCO Finland
NA
0.8
26.9
4215
38516
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
10.9
26.9
54
40
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.7
26.8
195
589
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
+∞
26.8
28
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
26.8
28
*
L01EF03
ATC
abemaciclib; oral
+∞
26.8
28
*
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
22.0
26.7
41
15
C03CA01
ATC
furosemide; systemic
1.4
26.7
1426
8443
A08
ICPC
Swelling
2.2
26.4
281
1035
SAA01
NOMESCO Finland
Simple examination of mouth
0.8
26.4
6104
53539
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
120.6
26.1
30
*
M05BA04
ATC
alendronic acid; oral
1.8
26.0
517
2414
1748X
ICD-9 Finland
Malignant neoplasm of female breast, Other specified sites of female breast
+∞
25.8
27
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
25.8
27
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.4
25.6
130
308
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.6
25.2
475
6016
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
25.2
178
529
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
25.1
613
3043
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.8
24.9
3820
35104
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.8
24.9
74
103
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.5
24.9
890
4854
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
24.8
26
*
1CD01
NOMESCO Finland
NA
+∞
24.8
26
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
24.8
26
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
24.8
26
*
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
+∞
24.8
26
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
24.8
26
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
217.8
24.4
27
*
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.7
24.4
1066
11516
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
24.3
252
919
GA5AA
NOMESCO Finland
Rib X-ray examination
8.9
24.2
54
49
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
112.6
24.2
28
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.7
24.2
175
528
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
24.0
3343
22749
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
23.9
234
830
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
23.9
25
*
N05BA04
ATC
oxazepam; oral
1.3
23.8
2229
14401
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
16.1
23.6
40
20
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
23.4
869
4777
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
108.5
23.3
27
*
OAB47
SPAT
NA
0.4
23.2
105
2027
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.8
23.0
2293
22163
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
22.9
24
*
B01AB04
ATC
dalteparin; parenteral
2.0
22.9
318
1314
R83
ICPC
Respiratory infection other
0.8
22.8
1702
17051
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
21.7
22.8
35
13
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
22.5
2045
13144
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
104.5
22.4
26
*
HAA01
NOMESCO Finland
Suture of mammary gland
72.4
22.3
27
*
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
5.0
22.2
75
122
J01CE08
ATC
benzathine benzylpenicillin; parenteral
4.7
22.2
79
136
X79
ICPC
Benign neoplasm breast female
24.1
22.2
33
11
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.8
22.1
4848
43168
D05
ICD-10 Finland
Carcinoma in situ of breast
+∞
22.0
23
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
22.0
23
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
22.0
23
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
22.0
23
*
335
Kela drug reimbursment
Lapatinib
+∞
22.0
23
*
1DB03
NOMESCO Finland
NA
+∞
22.0
23
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
38.8
21.8
29
6
ZZS50
NOMESCO Finland
Insertion of tissue expander
45.0
21.6
28
5
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
21.0
22
*
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.6
21.0
158
488
WX725
NOMESCO Finland
Noninvasive ventilation
1.9
20.7
313
1336
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
20.7
739
4025
ZZR70
NOMESCO Finland
Perforator flaps
96.4
20.5
24
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
14.5
20.5
36
20
QBA10
NOMESCO Finland
Incision of skin of trunk
3.6
20.5
97
219
L95
ICPC
Osteoporosis
2.4
20.3
176
587
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.2
20.3
216
797
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
20.1
446
2154
ZXA10
NOMESCO Finland
Bilateral
1.4
20.1
1296
7896
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
20.1
325
1420
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
20.1
21
*
8530/3-C50.9
ICD-O-3
Inflammatory carcinoma of breast, NOS
+∞
20.1
21
*
5BX04
NOMESCO Finland
NA
+∞
20.1
21
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
20.1
21
*
8500/2-C50.5
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast
+∞
20.1
21
*
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
+∞
20.1
21
*
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
+∞
20.1
21
*
M05BA06
ATC
ibandronic acid; systemic
2.7
19.9
139
413
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.6
19.9
149
461
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
5.7
19.9
59
83
LCA06
NOMESCO Finland
Biopsy of endometrium
1.3
19.9
1670
10596
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
5.1
19.8
65
103
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
50.2
19.7
25
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
50.2
19.7
25
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
176.8
19.7
22
*
M54.5
ICD-10 Finland
Low back pain
0.8
19.7
2232
21339
E66.8
ICD-10 Finland
Other obesity
0.6
19.6
248
3458
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.5
19.6
154
490
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
19.5
4299
38474
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.6
19.4
92
208
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
34.8
19.2
26
6
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
+∞
19.1
20
*
8524/3-C50.4
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast
+∞
19.1
20
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
19.1
20
*
1BC02
NOMESCO Finland
NA
+∞
19.1
20
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
19.1
20
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
19.1
20
*
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
0.6
18.9
396
4906
WW200
SPAT
NA
0.7
18.8
532
6208
WF001
NOMESCO Finland
Preoperative radiotherapy
168.7
18.8
21
*
R18
ICD-10 Finland
Ascites
3.8
18.7
83
178
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
18.7
123
353
G43
ICD-10 Finland
Migraine
0.5
18.6
180
2699
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
18.4
792
8605
N02AA01
ATC
morphine; systemic, rectal
5.9
18.4
53
72
M54.4
ICD-10 Finland
Lumbago with sciatica
0.7
18.4
954
10076
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
3.1
18.3
106
279
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.8
18.2
1435
14333
TQW40
NOMESCO Finland
Remowal of suture of skin
1.6
18.2
530
2754
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
18.2
1350
13586
8522/3-C50.2
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast
+∞
18.2
19
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
18.2
19
*
1XC14
NOMESCO Finland
NA
+∞
18.2
19
*
8000/3-C50.9
ICD-O-3
Neoplasm, malignant of breast, NOS
+∞
18.2
19
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
18.2
19
*
17409
ICD-8 Finland
Malignant neoplasm of breast, Unspecified
+∞
18.2
19
*
THA00
NOMESCO Finland
Needle biopsy of mamilla
8.5
18.1
41
39
NF3AA
NOMESCO Finland
Femur X-ray examination
2.9
18.0
111
305
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
17.9
17.9
29
13
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.1
17.9
204
779
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
59.0
17.8
22
*
SGA01
NOMESCO Finland
Tooth opening as first aid
0.7
17.8
956
10049
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
84.4
17.8
21
*
SPAT1308
SPAT
Sexual health counselling
0.7
17.6
423
5099
S76
ICPC
Skin infection other
1.8
17.6
300
1336
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
17.6
581
3111
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
17.4
105
284
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
0.7
17.4
622
6965
OAB39
NOMESCO Finland
Sexual health guidance
+∞
17.2
18
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
17.2
18
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
17.2
18
*
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
+∞
17.2
18
*
-1
ICD-10 Finland
NA
1.7
17.1
370
1775
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.8
17.1
1564
15356
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.9
17.1
243
1015
E0000UV
ATC
NA
1.2
17.0
3468
24361
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.5
16.9
686
3840
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
6.7
16.8
44
53
9702
FHL
Breast exploration and possible tumor removal
2.6
16.7
123
379
M77.1
ICD-10 Finland
Lateral epicondylitis
0.7
16.4
428
5076
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
2.1
16.4
196
766
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.2
16.3
14
615
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
16.3
274
1216
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
5.6
16.3
49
71
WE200
NOMESCO Finland
Profylactive therapy of malignancy with hormones
+∞
16.2
17
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
16.2
17
*
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
+∞
16.2
17
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
16.2
17
*
8097/3-C44.3
ICD-O-3
Basal cell carcinoma, nodular of skin of other and unspecified parts of face
+∞
16.2
17
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
16.2
17
*
L58.9
ICD-10 Finland
Radiodermatitis, unspecified
+∞
16.2
17
*
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
+∞
16.2
17
*
1740A
ICD-9 Finland
Malignant neoplasm of female breast, Nipple and areola
+∞
16.2
17
*
Z30.2
ICD-10 Finland
Sterilization
0.8
16.2
1111
11309
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.0
16.1
97
262
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.6
16.1
480
2510
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
15.9
307
1425
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
15.9
1212
7568
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
15.8
517
2763
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
15.7
729
4186
SPAT1379
SPAT
Health check-up of pregnant person
0.6
15.7
177
2542
HAB30
NOMESCO Finland
Excision of mamilla or areola
16.1
15.6
26
13
TJA10
NOMESCO Finland
Laparocentesis
14.5
15.5
27
15
HA1AT
SPAT
NA
8.8
15.5
34
31
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
15.4
168
631
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.8
15.3
4157
36833
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
15.3
16
*
C50.0
ICD-10 Finland
Malignant neoplasm: Nipple and areola
+∞
15.3
16
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
15.3
16
*
9708
FHL
Radical mastectomy (Halsted), also involves removal of the parasternal gland
+∞
15.3
16
*
8211/3-C50.4
ICD-O-3
Tubular adenocarcinoma of upper-outer quadrant of breast
+∞
15.3
16
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
15.3
16
*
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
+∞
15.3
16
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
15.3
16
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
50.8
15.1
19
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.6
15.1
69
153
E66.01
ICD-10 Finland
Obesity due to excess calories
0.7
15.1
407
4799
HA1DT
NOMESCO Finland
Mammary gland biopsy with MRI guidance
136.5
15.0
17
*
WE100
NOMESCO Finland
Profylactic cytostatic therapy
136.5
15.0
17
*
WGA10
NOMESCO Finland
Measurement of pain intensity
136.5
15.0
17
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
136.5
15.0
17
*
M53.1
ICD-10 Finland
Cervicobrachial syndrome
0.7
14.9
689
7415
5BA08
NOMESCO Finland
NA
5.5
14.9
45
66
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.2
14.8
58
112
SPAT1283
SPAT
Restricted health certificate
0.8
14.8
1284
12715
L57.0
ICD-10 Finland
Actinic keratosis
1.7
14.8
300
1413
JAL30
NOMESCO Finland
Omentectomy
4.1
14.8
59
116
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
0.8
14.8
1065
10783
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
5.8
14.8
43
60
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
14.7
589
3290
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.9
14.6
49
81
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
6.0
14.5
41
55
L03.3
ICD-10 Finland
Cellulitis of trunk
3.7
14.5
64
138
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.3
14.4
54
100
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
16.1
14.4
24
12
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
38.1
14.4
19
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
14.3
15
*
8522/3-C50.1
ICD-O-3
Infiltrating duct and lobular carcinoma of central portion of breast
+∞
14.3
15
*
XX9CN
NOMESCO Finland
NA
+∞
14.3
15
*
8522/3-C50.8
ICD-O-3
Infiltrating duct and lobular carcinoma of overlapping lesion of breast
+∞
14.3
15
*
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
+∞
14.3
15
*
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
14.3
15
*
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
+∞
14.3
15
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
14.3
15
*
8211/3-C50.2
ICD-O-3
Tubular adenocarcinoma of upper-inner quadrant of breast
+∞
14.3
15
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
14.3
15
*
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
6.5
14.3
38
47
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.3
14.3
134
469
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
0.6
14.2
272
3438
WX290
NOMESCO Finland
Other blockade of nerve
0.8
14.2
3513
31433
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
11.4
14.1
27
19
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
128.5
14.1
16
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
128.5
14.1
16
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
128.5
14.1
16
*
XX9XW
NOMESCO Finland
NA
3.7
14.1
62
134
ZXH09
SPAT
NA
0.4
14.0
54
1103
M03BC01
ATC
orphenadrine (citrate); systemic
0.8
14.0
1834
17384
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
9.7
14.0
29
24
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.5
13.9
108
343
MA3AE
NOMESCO Finland
Combined first trimester screening
0.2
13.9
17
605
N39.3
ICD-10 Finland
Stress incontinence
0.7
13.8
421
4853
D19
ICPC
Teeth/gum symptom/complaint
0.8
13.8
1797
17044
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.8
13.8
3619
32256
N64.8
ICD-10 Finland
Other specified disorders of breast
3.4
13.8
67
157
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
0.4
13.8
54
1097
SPAT1193
SPAT
Pap smear
0.7
13.8
753
7914
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.9
13.7
4607
40279
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.9
13.7
85
237
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
13.6
543
5977
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.7
13.4
596
6460
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
13.4
14
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
13.4
14
*
8510/3-C50.4
ICD-O-3
Medullary carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.4
14
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
13.4
14
*
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
13.4
14
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
13.4
14
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
13.4
14
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
13.4
14
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
13.4
14
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
13.4
14
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
13.4
14
*
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.7
13.3
761
7953
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.8
13.3
88
256
Z32.1
ICD-10 Finland
Pregnancy confirmed
0.7
13.2
346
4101
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
64.3
13.2
16
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.1
13.2
52
102
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
120.4
13.2
15
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
120.4
13.2
15
*
G47.3
ICD-10 Finland
Sleep apnoea
0.8
13.2
1018
10228
K02.1
ICD-10 Finland
Caries of dentine
0.9
13.2
4553
39771
A06AD11
ATC
lactulose; oral
1.4
13.2
799
4810
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.0
13.1
54
110
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
13.1
57
122
L03
ICPC
Low back symptom/complaint
0.8
13.1
1368
13283
B02.9
ICD-10 Finland
Zoster without complication
1.6
13.1
328
1646
N05CB02
ATC
barbiturates in combination with other drugs
2.7
13.0
92
277
R60.0
ICD-10 Finland
Localized oedema
1.4
13.0
638
3706
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
4.0
12.9
52
104
ZZA00
NOMESCO Finland
Split skin graft
2.3
12.9
117
405
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.7
12.9
447
5040
A14AB01
ATC
nandrolone; parenteral
9.9
12.8
26
21
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.0
12.7
73
194
KCD02
NOMESCO Finland
Transurethral resection of bladder
7.5
12.6
30
32
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.7
12.6
404
4615
R5110
SPAT
NA
2.1
12.5
146
568
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.7
12.5
397
4538
WB213
NOMESCO Finland
Adjuvant hormone therapy of malignancy
+∞
12.4
13
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
12.4
13
*
C507
ICD-10 Finland
NA
+∞
12.4
13
*
4CJ01
NOMESCO Finland
NA
+∞
12.4
13
*
8500/2-C50.3
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast
+∞
12.4
13
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.4
13
*
8500/2-C50.2
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast
+∞
12.4
13
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
12.4
13
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
12.4
13
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
12.4
13
*
SPAT1380
SPAT
Postpartum check-up
0.6
12.3
145
2058
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.7
12.3
261
1249
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.8
12.3
1667
15773
TQX05
NOMESCO Finland
Skin puncture, unspecified location
5.3
12.3
38
58
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.3
12.3
63
155
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
0.8
12.3
877
8902
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.1
12.2
39
62
SPAT1211
SPAT
Application of soft bandage
1.4
12.2
528
2995
M01AH05
ATC
etoricoxib; oral
0.9
12.2
5417
46566
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
16.1
12.1
20
10
ZXC82
NOMESCO Finland
Microsurgical
14.1
12.1
21
12
W78
ICPC
Pregnancy
0.7
12.0
323
3807
ZX100
NOMESCO Finland
Oral
2.7
12.0
84
254
A02BC05
ATC
esomeprazole; systemic
1.2
12.0
3694
26694
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
12.0
3149
22460
A55
ICPC
General and Unspecified, Local injection/infiltration
3.1
12.0
68
179
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.1
12.0
138
535
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
11.9
707
4242
N06AX11
ATC
mirtazapine; oral
1.2
11.9
2822
19952
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.3
11.9
32
41
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
0.8
11.8
1717
16149
G43.9
ICD-10 Finland
Migraine, unspecified
0.7
11.8
303
3605
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
9.1
11.8
25
22
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.8
11.7
212
968
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
3.1
11.7
66
172
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
4.1
11.7
46
91
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
4.9
11.6
38
62
D82
ICPC
Teeth/gum disease
0.8
11.6
2482
22569
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.6
11.6
34
49
NK6SN
NOMESCO Finland
Bone SPECT
40.1
11.6
15
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
11.5
913
5721
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
22.8
11.5
17
6
ZZR30
NOMESCO Finland
Flap of muscle
6.9
11.5
29
34
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.1
11.5
123
462
C54.19
ICD-10 Finland
Malignant tumor of endometrium, unspecified histology
+∞
11.5
12
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
11.5
12
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
11.5
12
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
11.5
12
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
11.5
12
*
1XC0V
NOMESCO Finland
NA
+∞
11.5
12
*
8523/3-C50.5
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast
+∞
11.5
12
*
L01AX03
ATC
temozolomide; systemic
+∞
11.5
12
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
11.5
12
*
ZZQ60
NOMESCO Finland
Free microvascular graft of nerve
+∞
11.5
12
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
11.5
12
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
11.5
12
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
11.5
12
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
11.5
12
*
WC402
NOMESCO Finland
Demanding antibody therapy of local recurrence of tumour
+∞
11.5
12
*
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
2.2
11.5
117
428
LGA21
NOMESCO Finland
Laparoscopic sterilisation by constriction of Fallopian tubes
0.7
11.4
618
6510
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.8
11.4
789
8045
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
56.3
11.4
14
*
PD2BD
NOMESCO Finland
Extensive CT angiography of pelvic organs
18.1
11.4
18
8
N05CF02
ATC
zolpidem; oral
1.2
11.4
1676
11320
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
0.7
11.3
334
3874
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
104.4
11.3
13
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
5.8
11.3
32
44
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.8
11.3
1599
15081
R74
ICPC
Upper respiratory infection acute
0.8
11.3
2116
19462
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
11.2
3533
25539
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.8
11.2
1847
17183
M25.5
ICD-10 Finland
Pain in joint
0.8
11.1
2193
20095
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.0
11.1
44
88
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
0.3
11.1
32
736
PJW20
NOMESCO Finland
Lymphovenous shunt
19.5
11.0
17
7
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.6
11.0
253
1243
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.3
11.0
56
138
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
30.1
10.9
15
*
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
0.8
10.9
703
7229
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
0.6
10.8
193
2471
B04
ICPC
Blood symptom/complaint
4.4
10.8
39
71
A07AA02
ATC
nystatin; oral
1.5
10.7
407
2251
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.9
10.7
3262
28919
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
10.7
392
2152
ZZA50
NOMESCO Finland
Full thickness skin graft
8.8
10.7
23
21
A87
ICPC
Complication of medical treatment
3.1
10.6
57
146
PWG00
NOMESCO Finland
Reoperation on peripheral vessels for thrombosis or embolism
17.1
10.6
17
8
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.4
10.5
51
121
SAA02
NOMESCO Finland
Basic examination of mouth
0.9
10.5
5493
46941
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
10.5
11
*
1XC07
NOMESCO Finland
NA
+∞
10.5
11
*
C50.62
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, lobular tumor
+∞
10.5
11
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
10.5
11
*
8401/3-C50.9
ICD-O-3
Apocrine adenocarcinoma of breast, NOS
+∞
10.5
11
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
10.5
11
*
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
+∞
10.5
11
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
10.5
11
*
8620/3-C56.9
ICD-O-3
Adult granulosa cell tumor of ovary of ovary
+∞
10.5
11
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
10.5
11
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
10.5
11
*
8246/3-C50.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of breast, NOS
+∞
10.5
11
*
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
0.8
10.5
711
7270
J05AB11
ATC
valaciclovir; oral
1.3
10.5
1088
7064
M03BX02
ATC
tizanidine; oral
0.9
10.5
5945
50527
SPAT1192
SPAT
Gynaecological examination
0.7
10.5
461
5000
ZXM40
NOMESCO Finland
Use of fluorescent substance
8.4
10.4
23
22
M54.2
ICD-10 Finland
Cervicalgia
0.7
10.4
329
3765
R51.80
ICD-10 Finland
Headache
0.8
10.3
861
8587
HAA00
NOMESCO Finland
Incision of mammary gland
5.6
10.3
30
43
R03AC02
ATC
salbutamol; inhalant
0.9
10.3
4394
38089
HA5CB
NOMESCO Finland
Galactography
4.4
10.2
37
68
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
10.2
1764
12099
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.9
10.2
3721
32597
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
10.1
658
6762
XW000
NOMESCO Finland
Bone marrow biopsy
2.0
10.1
130
527
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
28.1
10.1
14
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
6.5
10.1
26
32
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.5
10.1
87
1342
SPAT1197
SPAT
Extensive health check-up of expecting family
0.7
9.9
286
3327
R03DC03
ATC
montelukast; oral
0.8
9.8
1140
10977
G44.2
ICD-10 Finland
Tension-type headache
0.8
9.8
841
8363
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
34.8
9.8
13
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.8
9.7
64
187
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.0
9.7
127
521
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.1
9.7
112
438
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
9.6
652
3998
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
48.1
9.6
12
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
48.1
9.6
12
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
48.1
9.6
12
*
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.8
9.6
1691
15667
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
0.7
9.6
248
2941
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
9.6
10
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
9.6
10
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
9.6
10
*
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
9.6
10
*
8500/2-C50.1
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast
+∞
9.6
10
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
9.6
10
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
9.6
10
*
L01CB01
ATC
etoposide; systemic
+∞
9.6
10
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
9.6
10
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
9.6
10
*
8507/3-C50.1
ICD-O-3
Invasive micropapillary carcinoma of breast of central portion of breast
+∞
9.6
10
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
9.6
10
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
9.6
10
*
9020/3-C50.9
ICD-O-3
Phyllodes tumor, malignant of breast, NOS
+∞
9.6
10
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
9.6
10
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
9.6
10
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
9.6
10
*
8480/3-C50.2
ICD-O-3
Mucinous adenocarcinoma of upper-inner quadrant of breast
+∞
9.6
10
*
8524/3-C50.2
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast
+∞
9.6
10
*
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
+∞
9.6
10
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
9.6
10
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
9.6
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
9.5
301
1602
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
88.3
9.5
11
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
88.3
9.5
11
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
88.3
9.5
11
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
88.3
9.5
11
*
SPAT1151
SPAT
Treatment of major wounds
2.9
9.5
57
159
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.0
9.5
126
521
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
6.3
9.5
25
32
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.4
9.4
471
2747
SGC00
NOMESCO Finland
Local medication of root channels of tooth
0.8
9.4
619
6354
R09
ICPC
Sinus symptom/complaint
0.7
9.4
424
4580
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.4
9.3
77
258
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.3
9.3
765
4817
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
0.8
9.3
703
7093
K04.0
ICD-10 Finland
Pulpitis
0.8
9.3
537
5601
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.7
9.2
202
980
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
10.3
9.2
18
14
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
0.4
9.2
34
704
OAB44
SPAT
NA
0.5
9.2
86
1291
N03AG01
ATC
valproic acid; systemic, rectal
0.7
9.1
239
2827
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.1
9.1
105
409
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
0.7
9.1
404
4373
N01
ICPC
Headache
0.7
9.1
443
4733
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.7
9.1
187
893
R51
ICD-10 Finland
Headache
0.7
9.0
212
2562
A10AA01
ATC
NA
0.5
9.0
65
1058
21899
ICD-8 Finland
Uterine fibroma
1.9
9.0
132
567
N03AX09
ATC
lamotrigine; oral
0.6
8.9
194
2383
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
32.1
8.9
12
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
32.1
8.9
12
*
A10AA02
ATC
NA
0.5
8.9
88
1306
SDA02
NOMESCO Finland
Parodonthologic therapy
0.9
8.9
2347
21084
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.5
8.9
277
1472
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
0.7
8.8
299
3379
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
8.8
625
3862
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
2.3
8.8
81
287
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
8.7
1068
10231
K08.80
ICD-10 Finland
Toothache NOS
0.7
8.7
458
4838
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
7.0
8.6
21
24
D70.81
ICD-10 Finland
Neutropenia congenital
13.4
8.6
15
9
GEA00
NOMESCO Finland
Mediastinoscopy
4.2
8.6
32
61
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
4.7
8.6
29
50
N95
ICD-10 Finland
Menopausal and other perimenopausal disorders
0.6
8.6
167
2100
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
8.6
9
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
8.6
9
*
173
Kela drug reimbursment
Trastuzumab injection
+∞
8.6
9
*
8575/3-C50.9
ICD-O-3
Metaplastic carcinoma, NOS, of breast, NOS
+∞
8.6
9
*
8507/3-C50.2
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-inner quadrant of breast
+∞
8.6
9
*
8401/3-C50.4
ICD-O-3
Apocrine adenocarcinoma of upper-outer quadrant of breast
+∞
8.6
9
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
8.6
9
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
8.6
9
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
8.6
9
*
189
Kela drug reimbursment
Imatinib
+∞
8.6
9
*
158
Kela drug reimbursment
Everolimus
+∞
8.6
9
*
8543/3-C50.9
ICD-O-3
Paget disease and intraductal carcinoma of breast of breast, NOS
+∞
8.6
9
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
8.6
9
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
8.6
9
*
8507/3-C50.5
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-outer quadrant of breast
+∞
8.6
9
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
8.6
9
*
C55
ICD-10 Finland
Malignant neoplasm of uterus, part unspecified
+∞
8.6
9
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
8.6
9
*
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
+∞
8.6
9
*
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
+∞
8.6
9
*
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
+∞
8.6
9
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.6
9
*
L58.0
ICD-10 Finland
Acute radiodermatitis
80.3
8.6
10
*
WE198
NOMESCO Finland
Palliative cystotatic therapy
80.3
8.6
10
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
80.3
8.6
10
*
ZZA20
NOMESCO Finland
Split skin xenograft
80.3
8.6
10
*
L17
ICPC
Foot/toe symptom/complaint
0.8
8.6
1327
12440
N89
ICPC
Migraine
0.6
8.5
105
1464
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
8.5
110
1515
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.3
8.5
42
103
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
8.5
695
6945
R06AX27
ATC
desloratadine; oral
0.9
8.4
2276
20423
S93.4
ICD-10 Finland
Sprain and strain of ankle
0.8
8.4
532
5484
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
0.9
8.4
2530
22532
R21
ICPC
Throat symptom/complaint
0.8
8.4
1173
11100
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.6
8.3
98
1384
J45
ICD-10 Finland
Asthma
0.8
8.3
492
5120
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.1
8.3
97
380
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
2.8
8.3
52
148
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
8.3
759
4850
E66
ICD-10 Finland
Obesity
0.7
8.3
203
2429
HA1CG
SPAT
NA
17.4
8.3
13
6
WZA10
NOMESCO Finland
Long statement of health and health related matters
1.9
8.3
114
479
OAA80
SPAT
NA
0.6
8.3
155
1957
T89
ICPC
Diabetes insulin dependent
0.5
8.3
87
1262
OAB39
SPAT
NA
0.2
8.2
11
369
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.9
8.2
2876
25369
R06AE07
ATC
cetirizine; oral
1.1
8.2
4251
31613
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.8
8.2
560
5720
SPAT1255
SPAT
Intravenous administration of medicine
1.4
8.1
337
1905
HAC99
NOMESCO Finland
Other mastectomy
29.5
8.1
11
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.5
8.1
59
956
2506
FHL
Thyroidectomy
9.9
8.1
16
13
SPAT1109
SPAT
Analgesia with portable analgesic pump
7.3
8.0
19
21
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
0.5
8.0
47
819
A41.8
ICD-10 Finland
Other specified sepsis
2.7
8.0
53
158
G03DC05
ATC
[U] tibolone; oral
1.7
8.0
160
757
G02BA03
ATC
plastic IUD with progestogen
0.8
8.0
1497
13824
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.2
8.0
76
274
HAB20
NOMESCO Finland
Excision of lactiferous duct
3.4
7.8
37
88
X62
ICPC
Female Genital, Administrative procedure
40.1
7.8
10
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
40.1
7.8
10
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
40.1
7.8
10
*
M53.0
ICD-10 Finland
Cervicocranial syndrome
0.8
7.8
488
5039
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
0.7
7.8
269
3031
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
4.6
7.8
26
45
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
7.8
147
685
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
7.7
216
2522
L01
ICPC
Neck symptom/complaint
0.8
7.7
760
7448
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
8.0
7.7
17
17
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
10.0
7.7
15
12
C44
ICD-10 Finland
Other malignant neoplasms of skin
72.3
7.6
9
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
72.3
7.6
9
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
72.3
7.6
9
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
72.3
7.6
9
*
ZZQ80
NOMESCO Finland
Reanastomosis of blocked anastomosis in a microvascular graft
+∞
7.6
8
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
7.6
8
*
C739
ICD-10 Finland
NA
+∞
7.6
8
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
+∞
7.6
8
*
L02AB01
ATC
megestrol; oral (progestogens)
+∞
7.6
8
*
Y16
ICPC
Breast symptom/complaint male
+∞
7.6
8
*
8575/3-C50.4
ICD-O-3
Metaplastic carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.6
8
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
7.6
8
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
7.6
8
*
WB501
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of primary tumour
+∞
7.6
8
*
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
7.6
8
*
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
+∞
7.6
8
*
L01EH01
ATC
lapatinib; oral
+∞
7.6
8
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
7.6
8
*
C50.69
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, other or undeterminated histology
+∞
7.6
8
*
8523/3-C50.2
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-inner quadrant of breast
+∞
7.6
8
*
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
+∞
7.6
8
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
7.6
8
*
C50.60
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, no histological veryfication
+∞
7.6
8
*
8480/3-C50.1
ICD-O-3
Mucinous adenocarcinoma of central portion of breast
+∞
7.6
8
*
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
+∞
7.6
8
*
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.8
7.6
453
4711
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
0.6
7.6
131
1684
J01FF01
ATC
clindamycin; systemic
1.2
7.6
2122
15120
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.9
7.6
112
482
L04AX01
ATC
azathioprine; systemic
0.6
7.5
133
1701
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.3
7.5
513
3152
N02CC04
ATC
rizatriptan; oral
0.8
7.5
436
4542
L20.0
ICD-10 Finland
Besnier prurigo
0.7
7.5
295
3247
QBB99
NOMESCO Finland
Other procedure for wound of skin of trunk
5.6
7.5
21
30
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
0.6
7.4
95
1308
WX707
NOMESCO Finland
Fiberoscopic intubation
4.6
7.4
25
44
J05AB01
ATC
aciclovir; systemic
1.2
7.4
1828
12898
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.0
7.4
23
37
Z12.4
ICD-10 Finland
Special screening examination for neoplasm of cervix
0.6
7.4
156
1923
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
0.8
7.4
596
5967
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.7
7.4
333
3595
X50
ICPC
Female Genital, Medication/prescr/renewal
9.3
7.4
15
13
R10.1
ICD-10 Finland
Pain localized to upper abdomen
0.8
7.4
947
9035
N03AX16
ATC
pregabalin; oral
1.2
7.3
1882
13318
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
5.2
7.3
22
34
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
0.8
7.3
426
4438
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
7.3
85
336
T81.7
ICD-10 Finland
Vascular complications following a procedure, not elsewhere classified
4.5
7.3
25
45
3AA02
NOMESCO Finland
NA
26.8
7.2
10
*
C43
ICD-10 Finland
Malignant melanoma of skin
26.8
7.2
10
*
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
0.8
7.2
444
4594
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
0.7
7.2
204
2375
E10
ICD-10 Finland
Type 1 diabetes mellitus
0.4
7.2
26
542
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.0
7.2
89
360
J45.0
ICD-10 Finland
Predominantly allergic asthma
0.8
7.2
430
4466
VALMI
NOMESCO Finland
NA
0.9
7.2
1702
15442
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.8
7.2
115
512
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
0.8
7.1
452
4659
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
17.7
7.1
11
5
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.2
7.1
1291
8878
R96
ICPC
Asthma
0.7
7.1
366
3873
SPAT1229
SPAT
Assessment of need for aid
1.4
7.0
391
2327
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
0.8
7.0
421
4371
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
7.6
7.0
16
17
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
3.4
7.0
33
79
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
7.0
311
1782
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.7
7.0
46
138
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.8
7.0
124
569
SFA40
NOMESCO Finland
Replacement of krone of tooth
0.8
7.0
1323
12212
9719
FHL
Other measure in this category
5.1
6.9
21
33
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
6.9
963
6453
C10AA07
ATC
rosuvastatin; oral
0.8
6.9
1058
9936
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.8
6.9
922
8767
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
0.8
6.9
603
5982
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
0.8
6.9
668
6550
TQD05
NOMESCO Finland
Puncture of skin of lower limb
8.0
6.9
15
15
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.5
6.8
42
715
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
5.7
6.8
19
27
R5599
SPAT
NA
5.7
6.8
19
27
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.7
6.8
44
130
H01
ICPC
Ear pain/earache
0.8
6.8
494
5007
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
0.6
6.8
138
1714
6117B
ICD-9 Finland
Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]
2.9
6.8
40
112
R31
NOMESCO Finland
Adaptation training
5.0
6.8
21
34
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.9
6.8
1887
16932
EBA00
NOMESCO Finland
Extraction of tooth
0.9
6.7
1919
17199
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
0.7
6.7
331
3526
X77
ICPC
Malignant neopl genital female other
64.2
6.7
8
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
64.2
6.7
8
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
0.7
6.7
146
1786
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
0.8
6.7
535
5365
W12
ICPC
Contraception intrauterine
0.8
6.7
505
5097
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
0.5
6.7
44
732
S77
ICPC
Malignant neoplasm of skin
8.6
6.7
14
13
8211/3-C50.5
ICD-O-3
Tubular adenocarcinoma of lower-outer quadrant of breast
+∞
6.7
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
6.7
7
*
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
+∞
6.7
7
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
+∞
6.7
7
*
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
6.7
7
*
180
Kela drug reimbursment
Interferon alfa
+∞
6.7
7
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
+∞
6.7
7
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.7
7
*
L01XE10
ATC
[U] everolimus; oral
+∞
6.7
7
*
8500/2-C50.8
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast
+∞
6.7
7
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
6.7
7
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.7
7
*
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
+∞
6.7
7
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
6.7
7
*
8201/3-C50.9
ICD-O-3
Cribriform carcinoma, NOS, of breast, NOS
+∞
6.7
7
*
9710
FHL
Existence of a relapse
+∞
6.7
7
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
6.7
7
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
6.7
7
*
L01XE01
ATC
[U] imatinib; oral
+∞
6.7
7
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.7
7
*
1514
Kela drug reimbursment
NA
+∞
6.7
7
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
6.7
7
*
8500/3-C50.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of nipple
+∞
6.7
7
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
6.7
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
6.7
7
*
8010/3-C50.4
ICD-O-3
Carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.7
7
*
8504/2-C50.9
ICD-O-3
Encapsulated papillary carcinoma of breast, NOS
+∞
6.7
7
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
6.7
7
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
6.7
7
*
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
+∞
6.7
7
*
ZX002
NOMESCO Finland
Simple dose design for radiotherapy based on tomography - isocentric therapy
+∞
6.7
7
*
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
6.7
7
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
6.7
7
*
00044
NOMESCO Finland
NA
+∞
6.7
7
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
6.7
7
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
6.7
7
*
HAF10
NOMESCO Finland
Repair after excision of local recurrence of breast cancer using graft or flap
+∞
6.7
7
*
C51.21
ICD-10 Finland
Squamous cell carcinoma of the clitoris
+∞
6.7
7
*
3002
Kela drug reimbursment
Ribociclib
+∞
6.7
7
*
C50.6
ICD-10 Finland
Malignant neoplasm: Axillary tail of breast
+∞
6.7
7
*
H04AA01
ATC
glucagon; nasal, parenteral
0.5
6.7
40
688
XF400
NOMESCO Finland
ECG with 12 standard connections
1.2
6.7
784
5166
N02CC07
ATC
frovatriptan; oral
0.7
6.6
277
3023
LCD00
NOMESCO Finland
Hysterectomy
1.3
6.6
425
2588
M54
ICD-10 Finland
Dorsalgia
0.8
6.6
591
5851
P01BA02
ATC
hydroxychloroquine; oral
0.8
6.6
457
4657
TLC00
NOMESCO Finland
Insertion of intrauterine device
0.8
6.6
561
5583
ZX122
NOMESCO Finland
Intra-arterial
4.5
6.6
22
39
C09CA06
ATC
candesartan; oral
0.9
6.6
1343
12324
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
2.5
6.5
47
149
PWW99
NOMESCO Finland
Other reoperation on peripheral vessels or lymphatic system
9.5
6.5
13
11
A28
ICPC
Limited function/disability NOS
1.3
6.5
520
3266
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
0.6
6.5
118
1498
TGC00
NOMESCO Finland
Bronchial lavation
1.8
6.5
100
440
N02CC03
ATC
zolmitriptan; nasal, oral
0.8
6.5
391
4055
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
0.4
6.5
22
466
N76.0
ICD-10 Finland
Acute vaginitis
0.7
6.5
306
3280
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.2
6.5
1171
8047
M01AB05
ATC
diclofenac; systemic, rectal
0.9
6.5
6102
51118
J31.0
ICD-10 Finland
Chronic rhinitis
0.8
6.5
387
4016
X18
ICPC
Breast pain female
1.7
6.4
114
526
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
0.7
6.4
207
2355
D75
ICPC
Malignant neoplasm colon/rectum
10.7
6.4
12
9
E61.1
ICD-10 Finland
Iron deficiency
0.4
6.4
34
610
T82
ICPC
Obesity
0.7
6.4
169
1992
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
24.1
6.4
9
*
J01CR50
ATC
combinations of penicillins; systemic
7.1
6.4
15
17
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
0.8
6.4
742
7149
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
0.6
6.4
76
1063
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
12.6
6.3
11
7
S55
ICPC
Skin, Local injection/infiltration
4.6
6.3
21
37
N05AX12
ATC
aripiprazole; systemic
0.6
6.3
127
1576
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
4.3
6.3
22
41
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
6.3
404
2466
W85
ICPC
Gestational diabetes
0.5
6.3
58
871
Z37.0
ICD-10 Finland
Single live birth
0.8
6.2
517
5157
9101
FHL
Bone biopsy
5.7
6.2
17
24
N02CC06
ATC
eletriptan; oral
0.7
6.2
212
2386
S80.0
ICD-10 Finland
Contusion of knee
0.7
6.2
306
3259
J01MA02
ATC
ciprofloxacin; systemic
1.1
6.2
2817
20697
E66.00
ICD-10 Finland
Metabolic syndrome
0.7
6.2
187
2151
S97
ICPC
Chronic ulcer skin
1.5
6.2
192
1026
S21
ICPC
Skin texture symptom/complaint
1.2
6.2
642
4170
QWH99
NOMESCO Finland
Other reoperation in surgery of skin
6.7
6.2
15
18
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.3
6.2
439
2719
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
0.5
6.1
52
801
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
0.7
6.1
311
3296
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
0.8
6.1
524
5209
J01CF05
ATC
flucloxacillin; systemic
1.5
6.1
200
1081
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
32.1
6.1
8
*
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
32.1
6.1
8
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
32.1
6.1
8
*
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
32.1
6.1
8
*
N06AX21
ATC
duloxetine; oral
0.8
6.1
734
7046
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
1.6
6.0
150
760
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
1.9
6.0
84
359
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.1
6.0
65
252
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
0.7
6.0
209
2344
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
11.0
6.0
11
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
6282
10948
4.83
307.65
1.3
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
11817
38375
3.15
307.65
6.2
2.0
mmol/l
2.4
2.4
80.53
10861
32567
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
13009
57204
2.17
307.65
6.4
5.1
mmol/l
1.2
1.2
11.80
10738
48165
(3023368) Bacteria identified in Blood by Culture
6622
23293
2.22
307.65
4.0
3.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
12961
48902
2.75
307.65
3.6
3.5
—
—
—
0
0
(4035726)
6930
3678
17.41
307.65
1.4
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
1079
1530
4.79
307.65
1.3
1.3
nmol/l
0.3
0.4
6.66
671
1169
(1617658) Protocol used for examination of sentinel lymph nodes
2367
34
508.64
307.65
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
8744
27488
2.77
307.65
8.9
4.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
4629
306
124.46
307.65
4.0
1.2
u/ml
37.3
28.9
0.59
4474
278
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
16258
55646
4.36
307.65
9.3
3.5
umol/l
9.3
10.2
27.16
15861
51775
(40768804) Tissue Pathology biopsy report
12512
47164
2.67
307.65
2.4
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5436
6168
7.29
307.65
3.8
1.5
ug/l
13.3
9.5
0.60
4101
4487
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
2950
7697
2.73
307.65
3.0
1.5
u/ml
61.6
25.5
3.06
2863
7366
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1770
2073
5.97
307.65
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
3085
8138
2.71
307.65
1.7
2.1
g/l
0.2
0.2
18.58
2970
7447
(40768795) Lymph node Pathology biopsy report
968
272
24.25
307.65
1.1
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
10386
47139
1.82
307.65
3.9
3.5
g/l
35.7
36.3
21.93
9678
43073
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
2660
187
105.37
307.65
4.2
1.1
u/ml
46.8
20.9
9.59
2638
177
(3018418) pH of Serum or Plasma
8027
34079
1.84
307.65
4.3
3.1
ph
7.4
7.4
7.26
1924
5774
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
19906
90968
5.04
307.65
11.4
5.3
u/l
78.8
75.3
21.18
19440
84487
(3013650) Neutrophils [#/volume] in Blood by Automated count
16180
64518
3.33
307.65
12.3
6.6
e9/l
3.5
4.0
170.70
14681
55817
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
1328
76
121.30
307.65
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6786
23600
2.26
307.65
2.1
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
11925
51050
2.13
307.65
5.3
4.6
mmol/l
1.2
1.2
26.33
11065
45392
(3044640) Blood type and Crossmatch panel - Blood
9606
31477
2.75
307.65
2.1
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
681
162
28.29
307.65
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5127
1355
31.80
307.65
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
6169
26564
1.71
239.28
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
3597
13251
1.92
231.54
1.8
1.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
6091
26653
1.68
218.93
3.3
3.2
%
95.5
96.3
1.57
5953
25767
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
2584
8954
2.00
195.61
4.1
2.7
mmol/l
1.2
1.2
6.18
2396
7546
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
19631
116628
1.84
176.01
16.9
9.8
ml/min/173m2
80.9
80.8
0.20
17563
94129
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
4895
21212
1.65
175.99
3.0
2.2
mmol/l
2.5
2.4
42.83
4380
18172
(3032080) INR in Blood by Coagulation assay
8215
40710
1.50
162.17
6.9
7.1
inr
1.2
1.2
0.23
2510
11863
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
10785
56601
1.47
159.36
2.2
2.3
nmol/l
81.6
1689.9
0.50
9867
50908
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3709
15330
1.70
157.22
1.8
1.7
—
—
—
0
0
(3019225) pH of Specimen
2941
11440
1.78
153.97
4.3
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2650
10125
1.81
146.69
3.3
3.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
811
1973
2.75
135.35
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
11874
64849
1.42
130.27
3.8
3.8
mmol/l
6.5
6.6
4.15
11290
60117
(3012095) Magnesium [Moles/volume] in Serum or Plasma
3570
15346
1.62
127.21
2.9
2.3
mmol/l
0.8
0.8
4.29
3308
13994
(3019550) Sodium [Moles/volume] in Serum or Plasma
20719
127228
1.91
126.14
16.7
12.4
mmol/l
139.8
139.9
6.47
20330
123790
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
188
135
9.16
123.80
5.6
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
20729
127643
1.88
117.75
16.8
12.5
mmol/l
3.9
3.9
5.93
20314
123950
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
20098
122782
1.71
114.36
16.5
11.1
mg/l
21.2
19.2
13.79
16579
93918
(3044889) 12 lead EKG panel
14871
85591
1.41
111.16
3.7
3.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
853
2370
2.40
108.97
2.8
2.0
u/ml
1983.5
120.9
1.36
712
1912
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
569
1315
2.87
104.02
1.2
1.2
u/l
59.3
57.6
0.35
363
892
(3013512) EKG study
6606
33567
1.41
101.18
3.8
3.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
278
412
4.45
96.24
1.4
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
7340
38388
1.37
92.52
4.8
5.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2466
10426
1.61
91.41
1.7
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2462
10467
1.60
89.06
1.7
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
332
622
3.52
84.79
1.3
1.4
g/l
34.7
29.4
9.64
307
537
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
643
1792
2.38
81.44
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
616
1718
2.38
77.89
1.5
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1398
5367
1.75
73.75
1.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
483
1233
2.59
73.36
1.5
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
20961
131452
1.70
72.18
21.1
12.3
umol/l
68.6
69.1
2.85
20956
131390
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2036
8691
1.58
71.50
3.9
2.7
u/l
262.4
238.1
5.11
1911
8052
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
17463
121082
0.73
69.44
3.8
3.9
mmol/l
1.3
1.3
1.57
15556
111902
(3021589) Normoblasts [#/volume] in Blood
9373
52324
1.29
68.70
10.6
7.9
e9/l
0.0
0.0
3.23
7631
42902
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
18370
126308
0.71
68.32
4.3
4.4
mmol/l
4.9
4.9
0.35
16612
118004
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
18228
125474
0.72
67.96
4.2
4.4
mmol/l
1.6
1.6
13.10
16400
116795
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
759
2453
2.06
67.32
1.6
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
21013
132135
1.68
66.33
14.8
8.8
u/l
24.5
24.0
2.64
20585
127189
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7101
38360
1.31
65.77
3.9
2.7
u/l
34.9
30.6
2.18
6767
36252
(3019069) Monocytes/100 leukocytes in Blood
9757
55027
1.28
64.53
5.2
6.0
%
8.6
8.2
23.30
9127
51274
(4281824)
378
910
2.74
64.23
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
9987
56552
1.28
63.60
5.1
5.8
%
27.3
29.6
69.09
9276
52380
(3012441) Differential panel - Pleural fluid
244
454
3.54
63.04
1.4
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
294
624
3.10
62.15
1.2
1.1
u/l
72.8
77.6
0.57
258
479
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
295
628
3.10
62.06
1.2
1.1
u/l
17.0
20.4
0.62
253
465
(3023199) Leukocytes [#/volume] in Pleural fluid
280
577
3.20
62.05
1.3
1.4
e6/l
4197.0
3548.6
0.10
208
418
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
18772
128325
0.72
61.45
4.8
4.9
mmol/l
2.9
2.9
5.86
16884
119357
(3030467) Casts [#/volume] in Urine by Automated count
5551
29214
1.32
61.05
2.7
2.8
e6/l
0.5
0.4
1.43
4034
21556
(3004809) Band form neutrophils/100 leukocytes in Blood
439
1172
2.48
60.93
2.3
2.7
%
2.2
1.0
7.35
341
896
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
837
9667
0.55
60.79
1.6
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
9681
54801
1.27
60.75
5.0
5.7
%
2.7
2.9
18.78
8995
50716
(3002582) Erythrocytes [#/volume] in Urine
5960
31706
1.31
60.59
2.8
2.9
e6/l
97.3
67.6
0.61
4372
23659
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
746
2490
1.99
60.58
1.4
1.3
u/l
41.1
35.3
3.84
699
1909
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
168
243
4.54
59.97
2.0
2.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
253
503
3.31
59.29
1.4
1.4
e6/l
31740.0
41785.6
0.27
142
287
(36304419) Bacteria [Presence] in Urine
5450
28745
1.32
58.55
2.7
2.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
9372
53025
1.27
58.10
5.1
5.8
%
0.7
0.7
0.48
8710
49076
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
617
1951
2.10
57.92
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
617
1951
2.10
57.92
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
1209
12521
0.61
57.63
1.3
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
329
784
2.77
57.01
1.6
1.5
u/l
5.3
6.6
0.74
161
372
(3026008) Bacteria identified in Urine by Culture
7179
39395
1.28
56.72
3.2
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1057
4049
1.74
55.87
1.9
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
724
8496
0.54
55.35
1.6
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2639
12555
1.42
53.92
1.6
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
13453
79845
1.25
52.87
4.6
4.4
e6/l
2803.5
2300.8
0.29
151
922
(3018010) Neutrophils/100 leukocytes in Blood
9759
55908
1.25
52.24
5.0
5.6
%
57.1
56.2
8.21
9085
52008
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
965
3673
1.75
52.12
1.8
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3254
16166
1.37
51.30
2.5
2.5
e6/l
4.0
5.1
3.96
1626
8356
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1204
4906
1.64
50.55
4.9
6.4
mmol/l
25.2
25.1
0.60
1190
4855
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
443
1294
2.26
50.51
2.9
2.0
u/ml
162.7
255.2
0.33
400
1156
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1677
7398
1.52
50.11
1.5
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
303
741
2.69
50.09
1.2
1.2
u/l
17.5
20.7
0.48
267
636
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
6877
37983
1.26
49.83
2.8
3.0
—
0.1
—
0
6
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
306
755
2.67
49.75
1.2
1.2
u/l
68.5
80.1
1.62
283
665
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
320
809
2.61
49.64
1.4
1.1
ug/l
1.6
2.8
1.92
188
645
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
804
2948
1.81
49.19
1.9
1.8
ug/l
1.8
2.1
0.41
713
2511
(3045788) Cell count panel - Pleural fluid
219
452
3.19
48.52
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
471
1443
2.16
47.92
1.3
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
3156
26428
0.74
47.36
1.3
1.3
u/ml
9.5
12.2
1.63
1201
10616
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
205
412
3.27
47.35
1.3
1.3
u/l
393.0
356.7
0.13
196
378
(3018095) Leukocytes [#/volume] in Urine
7024
39154
1.25
46.08
3.3
3.4
e6/l
94.6
109.2
1.04
4741
26318
(3026782) Osmolality of Urine
3909
20259
1.32
45.85
2.5
2.6
mosm/kgh2o
499.5
506.3
0.92
3310
16937
(3051651) Icteric interference index of Serum or Plasma
222
479
3.05
45.81
2.3
3.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
11342
81519
0.81
45.65
2.7
2.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
3326
27500
0.75
45.31
1.3
1.3
iu/ml
32.9
36.1
0.49
1051
9065
(3052851) Hemolysis interference index of Serum or Plasma
833
3202
1.73
43.41
2.7
2.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
2044
9710
1.41
41.45
5.5
6.4
mmol/l
1.1
1.4
2.62
1693
7591
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
500
6003
0.53
40.98
1.4
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
574
6600
0.56
40.48
1.3
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
209
473
2.90
39.85
1.4
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
297
808
2.42
39.76
1.4
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2036
9734
1.40
39.72
5.6
6.4
kpa
5.1
5.1
2.36
1944
9257
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
341
990
2.27
39.53
1.4
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
2034
9731
1.40
39.52
5.6
6.4
kpa
13.6
12.2
19.76
1943
9247
(3002385) Erythrocyte distribution width [Ratio]
16613
102265
1.24
38.53
21.4
13.2
%
13.8
13.6
29.95
16416
99877
(3014111) Lactate [Moles/volume] in Serum or Plasma
1620
7478
1.45
38.32
5.0
6.3
mmol/l
1.3
1.3
0.52
1566
7216
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
273
727
2.47
38.25
1.5
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
882
3587
1.63
37.19
1.4
1.4
pmol/l
139.7
69.0
6.14
859
3514
(3036782) Glucose [Moles/volume] in Pleural fluid
209
496
2.77
36.66
1.3
1.2
mmol/l
6.3
6.9
1.98
197
452
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
155
311
3.27
36.02
1.2
1.3
u/l
11.5
11.9
0.09
143
267
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1680
7895
1.42
35.99
6.1
7.2
g/l
118.0
120.7
7.57
1627
7568
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
177
387
3.00
35.84
1.6
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
177
387
3.00
35.84
1.6
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
177
387
3.00
35.84
1.6
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
1500
6911
1.45
35.77
5.9
7.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
377
4734
0.51
35.71
1.4
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
177
389
2.99
35.54
1.6
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6308
47303
0.82
35.13
2.7
2.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
2402
20122
0.75
34.66
1.3
1.4
titre
514.7
605.8
1.75
540
4522
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
5522
30730
1.23
34.45
2.6
2.7
ng/l
1091.0
1079.9
0.07
4683
25690
(3014576) Chloride [Moles/volume] in Serum or Plasma
2234
11089
1.35
34.36
5.4
6.0
mmol/l
104.3
104.1
0.71
2187
10835
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
284
814
2.30
33.97
1.5
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2805
14433
1.31
33.60
1.9
1.9
s
29.3
29.4
0.37
2720
13924
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
585
2188
1.77
33.54
2.4
3.3
u/ml
0.4
0.4
0.10
342
1288
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
141
280
3.30
33.32
1.8
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
141
280
3.30
33.32
1.8
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
243
656
2.43
33.16
1.5
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
243
656
2.43
33.16
1.5
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
243
656
2.43
33.16
1.5
1.3
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
55
46
7.83
32.72
1.5
3.7
mg/l
1.1
2.0
1.02
28
36
(3016502) Oxygen saturation in Arterial blood
1773
8550
1.38
32.61
5.8
6.8
%
96.2
95.5
4.48
1715
8197
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
142
289
3.22
32.33
1.8
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1853
9025
1.37
32.05
3.1
4.0
%
1.8
0.7
25.53
723
1689
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
17029
116209
0.82
31.36
5.3
5.5
mmol/mol
39.3
39.2
1.00
15424
108064
(3013115) Eosinophils [#/volume] in Blood
10352
61568
1.18
30.68
5.0
5.7
e9/l
0.2
0.2
37.33
8858
54490
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
970
4226
1.52
30.44
6.8
8.5
mmol/l
24.6
24.6
0.31
906
3886
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
66
76
5.69
30.08
1.2
1.3
ug/l
514.3
33.3
0.99
48
44
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
220
598
2.42
29.64
1.4
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1917
9524
1.34
29.08
2.6
3.3
ng/l
75.3
81.5
3.10
1646
8067
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
685
6942
0.63
28.89
1.5
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
10213
60858
1.18
28.85
5.0
5.6
e9/l
1.7
1.9
46.14
8793
53995
(3008898) HLA-B27 [Presence]
446
5011
0.57
28.78
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
232
657
2.32
28.60
4.8
1.1
u/ml
87.1
268.7
2.22
61
147
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
3377
18130
1.26
28.43
2.4
2.4
e6/l
2.3
1.3
0.52
1740
10245
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1867
9317
1.34
27.43
3.5
2.2
ml/min/173m2
67.8
67.7
0.01
776
3638
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
640
2610
1.62
26.73
2.2
2.8
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
84
135
4.08
26.67
1.4
1.2
nmol/l
0.2
0.4
1.35
56
88
(3035880) pH of Pleural fluid
123
259
3.11
26.63
1.3
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
9909
59142
1.17
26.54
4.9
5.5
e9/l
0.5
0.5
1.22
8387
51522
(3006315) Basophils [#/volume] in Blood
9952
59421
1.17
26.52
4.9
5.6
e9/l
0.0
0.0
9.70
8411
51715
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
609
2464
1.63
26.25
2.0
2.6
g/l
3.5
3.6
0.72
590
2318
(3001122) Ferritin [Mass/volume] in Serum or Plasma
7722
55776
0.85
25.14
2.5
2.8
ug/l
133.2
89.2
27.30
7044
51903
(3051611) Lipemic interference index of Serum or Plasma
326
1112
1.93
25.07
2.5
3.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
221
651
2.23
24.96
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
183
2584
0.46
24.56
1.3
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
302
1011
1.96
24.52
1.4
1.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
87
155
3.68
24.18
1.4
1.3
%
69.5
55.2
2.97
74
123
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
390
1430
1.80
24.01
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
263
847
2.04
23.77
2.5
2.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1569
7829
1.33
22.95
2.6
1.5
g/l
66.1
67.0
4.65
1414
6951
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
236
742
2.09
22.75
3.8
1.5
nmol/l
4.9
3.4
1.07
230
695
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
252
813
2.04
22.70
1.1
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
100
205
3.20
22.66
2.1
3.5
%
48.6
54.5
1.39
95
197
(3021440) Promyelocytes/100 leukocytes in Blood
1723
8746
1.31
22.32
3.2
4.0
%
0.3
0.1
14.38
660
1587
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
683
2960
1.52
22.00
1.7
2.0
%
95.7
96.9
0.65
618
2666
(46235355) HIV 1 and 2 tests - Meaningful Use set
1858
15230
0.78
21.80
1.5
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
4080
30763
0.84
21.46
1.2
1.3
u/ml
1.4
1.5
0.06
943
8621
(44790047)
251
834
1.98
20.90
1.3
1.4
—
—
—
0
0
(44806118)
251
834
1.98
20.90
1.3
1.4
—
—
—
0
0
(44790048)
251
834
1.98
20.90
1.3
1.4
—
—
—
0
0
(44790049)
251
834
1.98
20.90
1.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1641
8354
1.31
20.78
3.1
3.8
%
1.2
0.5
12.26
498
1275
(3048689) Calprotectin [Mass/mass] in Stool
2079
16721
0.79
20.71
1.9
2.1
ug/g
129.4
113.2
0.61
1564
12887
(3000850) Epithelial cells [#/volume] in Urine
3948
22183
1.20
20.59
2.3
2.4
e6/l
7.8
7.4
0.67
3416
19139
(3001019) Free T4 and TSH panel - Serum or Plasma
983
8734
0.72
20.46
1.7
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1157
5616
1.36
20.26
1.4
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
1034
9101
0.73
20.26
1.3
1.3
u/ml
187.4
188.7
0.02
932
8446
(3019150) Specific gravity of Urine by Refractometry
3583
27205
0.83
20.18
4.1
4.3
kg/l
1.0
1.0
0.69
580
4177
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
332
1224
1.78
20.16
1.4
1.3
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
71
125
3.72
20.13
1.4
1.3
%
12.4
25.0
3.58
63
114
(3001893) Eosinophils/100 leukocytes in Pleural fluid
74
135
3.59
19.98
1.4
1.3
%
2.1
2.0
0.03
61
113
(3003338) MCHC [Mass/volume]
15564
106012
0.86
19.95
22.8
14.4
g/l
330.0
330.8
25.19
15468
105258
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
918
4308
1.41
19.69
7.2
8.7
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
31
24
8.45
19.52
4.2
1.1
estimate
0.0
—
—
5
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
225
738
2.00
19.46
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
15673
106624
0.87
19.27
4.4
4.4
pmol/l
14.9
14.7
18.19
14091
98451
(3017354) Segmented neutrophils/100 leukocytes in Blood
236
791
1.96
19.22
2.5
2.5
%
57.3
59.5
0.61
148
524
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
18000
121159
0.85
19.20
5.3
5.3
mu/l
2.0
2.1
0.17
16317
112593
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
144
397
2.38
19.02
1.5
1.4
u/l
11.5
12.7
1.62
137
384
(3015171) Extractable nuclear Ab [Units/volume] in Serum
691
6428
0.69
18.88
1.3
1.3
u/ml
1.8
0.8
0.73
57
591
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
630
2779
1.49
18.72
2.3
2.3
%
192.0
175.4
4.49
603
2591
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
71
132
3.52
18.69
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
141
391
2.36
18.41
1.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
143
402
2.33
18.13
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
303
1124
1.77
18.08
1.4
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
373
3891
0.62
17.90
1.6
1.6
iu/ml
0.2
5.7
0.69
88
781
(40768443) Skin Pathology biopsy report
1062
5196
1.35
17.68
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
153
449
2.23
17.60
1.5
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
294
3235
0.59
17.59
1.7
1.7
mu/l
323.3
328.4
0.07
273
2888
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
50
75
4.36
17.39
1.4
1.1
ug/l
12.6
2.4
0.44
27
45
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
615
2744
1.48
17.30
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1922
10205
1.25
17.28
2.1
2.2
u/l
41.1
36.9
0.81
1642
8580
(3027945) Reticulocytes/100 erythrocytes in Blood
1882
9970
1.25
17.26
2.1
2.2
%
1.9
1.8
2.24
1663
8628
(3022217) INR in Platelet poor plasma by Coagulation assay
2463
13438
1.22
17.19
22.0
21.1
inr
1.3
1.3
0.10
342
1940
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5218
30422
1.16
16.85
1.4
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
198
657
1.98
16.66
1.1
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
484
2072
1.54
16.59
1.3
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
1633
8561
1.27
16.35
1.4
1.3
iu/l
42.3
36.1
9.76
1398
7566
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
18366
123122
0.85
16.10
4.5
4.5
mmol/l
5.8
5.8
3.54
16486
113628
(3010421) pH of Blood
546
2418
1.49
15.97
3.3
3.3
ph
7.4
7.4
2.13
451
1966
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1553
12552
0.79
15.91
1.5
1.6
%
1.4
1.3
0.59
1328
11084
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2286
12492
1.22
15.64
3.7
4.5
mmol/l
1.0
1.0
0.88
2083
11448
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2286
12518
1.21
15.30
2.4
2.1
umol/l
8.3
6.1
4.43
1932
10477
(40761511) CBC panel - Blood by Automated count
20185
129178
1.22
15.28
15.4
10.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
466
2018
1.52
15.20
3.5
3.4
mmol/l
2.6
2.6
0.03
349
1399
(3013290) Carbon dioxide [Partial pressure] in Blood
466
2019
1.52
15.16
3.5
3.4
kpa
5.0
5.1
0.47
451
1967
(3028271) Lactate [Moles/volume] in Capillary blood
353
1436
1.62
15.09
1.8
1.8
mmol/l
1.8
1.7
0.92
343
1406
(3033799) Differential panel - Peritoneal fluid
74
163
2.97
15.09
1.5
2.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
400
3943
0.66
14.84
1.3
1.3
miu/ml
241.9
219.8
0.57
184
1963
(40761536) Microorganisms panel - Urine sediment
1778
9517
1.24
14.81
4.2
3.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
84
1300
0.42
14.54
1.2
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
263
2832
0.60
14.50
1.8
1.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
466
2039
1.50
14.50
3.5
3.5
kpa
8.5
8.6
0.32
451
1987
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
80
190
2.76
14.33
1.7
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
599
2765
1.43
14.18
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
611
5516
0.72
14.04
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
790
3834
1.36
13.91
1.7
1.9
s
21.5
21.2
0.86
687
3198
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
510
4740
0.70
13.90
1.7
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
203
726
1.83
13.78
2.3
2.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
239
2600
0.60
13.76
1.9
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
135
1726
0.51
13.75
1.4
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
83
206
2.64
13.72
1.6
2.2
e6/l
2960.8
1199.1
0.38
49
140
(3013139) Helicobacter pylori Ag [Presence] in Stool
1262
10267
0.79
13.64
1.2
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
275
2879
0.62
13.50
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
273
2853
0.62
13.30
1.8
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
275
2868
0.62
13.28
1.8
1.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
0
+∞
13.15
1.1
0.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
41
836
0.32
13.12
1.2
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
434
1913
1.49
13.08
2.4
2.4
%
16.0
16.3
0.92
192
961
(3025159) Blasts/100 leukocytes in Blood
1573
8428
1.24
12.97
3.3
4.1
%
0.6
0.1
1.01
547
1404
(3044007) Cell count panel - Peritoneal fluid
70
164
2.79
12.89
1.7
2.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
93
253
2.41
12.81
1.1
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
114
1500
0.49
12.73
1.3
1.4
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
42
71
3.87
12.70
1.4
1.3
%
13.8
12.8
0.08
23
36
(1001926) Buprenorphine [Presence] in Urine by Screen method
193
2169
0.58
12.66
2.0
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
74
181
2.68
12.61
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
277
1117
1.63
12.36
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2439
13694
1.18
12.32
2.1
2.5
%
21.4
22.5
2.99
2133
11573
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
432
4045
0.69
12.32
1.7
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
67
1059
0.41
12.31
1.5
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
268
1073
1.64
12.30
2.4
2.8
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
74
184
2.63
12.24
3.2
1.2
ng/l
62.6
59.3
0.06
21
55
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
970
8038
0.78
12.22
1.5
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
44
80
3.60
12.08
1.5
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1801
13937
0.83
11.94
1.6
1.6
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
74
187
2.59
11.88
1.6
1.9
e6/l
4248.4
20465.7
0.71
35
92
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
109
1416
0.50
11.75
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
109
1415
0.50
11.72
1.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
261
1053
1.63
11.66
1.7
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1353
7215
1.24
11.66
2.3
2.2
e9/l
70.4
71.5
0.46
997
5395
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
109
1411
0.50
11.62
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
109
1410
0.50
11.60
1.3
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
90
254
2.32
11.50
1.8
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
178
1989
0.58
11.47
1.1
1.1
u/ml
1.0
1.5
0.76
37
426
(3003888) Timothy IgE Ab [Units/volume] in Serum
205
2207
0.60
11.40
1.1
1.1
u/ml
4.1
3.1
0.35
77
1000
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
233
2433
0.62
11.38
1.1
1.1
u/ml
1.4
1.1
0.17
77
841
(4034850)
496
4468
0.72
11.30
11.3
8.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
346
1502
1.51
11.29
3.1
5.2
iu/ml
831.0
861.8
0.02
31
199
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1505
11777
0.82
11.22
1.8
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1349
10659
0.82
11.09
1.2
1.2
iu/ml
163.5
151.1
0.52
527
4345
(3012544) pH of Venous blood
1602
8739
1.21
11.08
2.8
3.5
ph
7.4
7.4
—
6
34
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
1441
11300
0.82
10.97
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
4694
27843
1.13
10.95
1.6
1.7
mg/l
1.2
0.9
6.35
3608
21113
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
132
443
1.95
10.95
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
132
443
1.95
10.95
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
4925
35176
0.89
10.78
3.5
3.7
mg/mmol
5.6
6.8
1.19
2553
20033
(3014133) Dog dander IgE Ab [Units/volume] in Serum
156
1772
0.57
10.73
1.0
1.1
u/ml
4.3
3.5
0.28
45
612
(3008401) Mugwort IgE Ab [Units/volume] in Serum
197
2109
0.61
10.73
1.1
1.1
u/ml
1.5
0.8
0.47
70
785
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
165
601
1.80
10.68
1.3
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
282
1185
1.56
10.68
1.8
1.7
%
90.1
90.1
0.03
277
1167
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
35
59
3.88
10.66
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
332
1448
1.50
10.63
1.4
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
232
934
1.63
10.50
5.0
6.0
mg/l
12.5
12.0
0.90
208
842
(3020779) Urea [Moles/volume] in Serum or Plasma
1279
6861
1.23
10.44
5.1
6.5
mmol/l
8.6
9.3
3.28
1220
6507
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
469
4202
0.72
10.36
1.5
1.8
g/l
0.2
0.2
0.53
434
3975
(3037467) Urinalysis macro (dipstick) panel - Urine
13378
83967
1.10
10.35
4.3
4.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
165
608
1.78
10.30
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1745
13365
0.84
10.26
1.4
1.5
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
55
129
2.79
10.20
1.2
1.5
g/l
31.8
21.2
4.07
42
85
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
868
7125
0.79
10.13
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1534
8406
1.21
10.13
2.8
3.5
mmol/l
2.1
2.1
0.18
1272
6984
(3023430) Cat dander IgE Ab [Units/volume] in Serum
146
1659
0.57
10.09
1.0
1.1
u/ml
2.7
3.5
0.32
49
610
(3009508) Creatinine [Moles/volume] in Urine
4947
35211
0.89
10.06
2.8
3.0
mmol/l
6.3
6.6
4.73
3992
29680
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
332
1466
1.49
10.04
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
333
1472
1.48
10.02
1.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
178
1919
0.60
10.02
2.1
2.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
122
1453
0.55
9.99
1.0
1.0
u/ml
0.4
0.3
0.10
22
278
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
329
1452
1.49
9.98
1.4
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
93
1201
0.50
9.93
1.6
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
329
1456
1.48
9.85
1.4
1.3
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
32
54
3.87
9.76
1.2
1.3
%
19.5
28.3
0.61
25
40
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
6813
47612
0.91
9.67
4.0
4.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2616
15042
1.15
9.67
2.0
2.3
g/l
2.4
2.4
1.80
2412
13736
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
486
4279
0.74
9.62
1.5
1.8
g/l
1.2
1.2
0.08
451
4049
(3020961) Endomysium IgA Ab [Titer] in Serum
816
6684
0.79
9.37
1.1
1.1
titre
432.1
182.8
0.76
17
143
(3012516) Albumin [Mass/volume] in Urine
4701
33443
0.90
9.35
2.8
3.1
mg/l
463.4
412.9
0.24
2436
18696
(3026493) Urate [Moles/volume] in Serum or Plasma
4221
30199
0.89
9.29
2.2
2.0
umol/l
5170.1
3993.6
1.02
3567
26033
(40763480) Human metapneumovirus Ag [Presence] in Specimen
22
28
5.14
9.23
1.0
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
82
246
2.18
9.19
1.2
1.8
u/ml
165831.1
54000.7
—
8
32
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1527
8441
1.19
9.18
2.8
3.5
kpa
5.8
5.9
1.11
1476
8193
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
335
1517
1.45
8.97
1.4
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
466
4077
0.74
8.87
1.3
1.3
u/ml
4.8
6.1
0.19
45
452
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
525
4510
0.75
8.79
1.2
1.3
u/ml
22.2
41.9
1.14
28
292
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
3184
23088
0.88
8.75
1.4
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
475
4134
0.74
8.73
1.3
1.3
u/ml
7.9
6.9
0.13
77
712
(3000494) Fungus identified in Specimen by Culture
2417
13921
1.15
8.70
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
103
1234
0.54
8.68
1.3
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
238
1018
1.53
8.45
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
98
1179
0.54
8.39
1.3
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
48
117
2.68
8.37
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
215
2129
0.66
8.36
2.0
1.8
nmol/l
0.9
0.8
0.43
173
1765
(3047352) Trisomy 18 risk [Likelihood] in Fetus
99
1184
0.54
8.31
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
3513
25236
0.89
8.18
1.4
1.3
g/l
2.2
2.3
0.71
1797
15091
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
383
1809
1.39
8.16
1.4
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
56
151
2.43
8.03
1.1
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
259
1142
1.49
8.00
1.8
2.5
u/ml
4758.8
914.2
0.40
11
44
(3023511) Choriogonadotropin [Units/volume] in Urine
168
1733
0.63
7.93
1.8
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
7108
43688
1.09
7.87
3.3
3.2
ng/l
30.3
49.5
1.55
4888
25988
(40761535) Cells panel - Urine sediment
1264
9721
0.84
7.78
3.3
3.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
3607
21455
1.12
7.73
3.3
3.4
ng/l
131.6
312.8
8.65
2742
14940
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
50
131
2.50
7.62
1.0
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
772
4063
1.25
7.59
2.9
4.1
mmol/l
24.5
24.4
0.33
684
3613
(3029634) Reagin Ab [Titer] in Serum by VDRL
110
1243
0.58
7.58
1.4
1.5
—
3.1
—
0
8
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1037
5633
1.21
7.56
5.7
6.3
mmol/l
25.2
24.8
3.38
970
5206
(3049717) Cytology report of Urine Cyto stain
495
2469
1.32
7.45
2.4
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
133
510
1.71
7.39
1.6
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
247
1098
1.47
7.37
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
2827
16627
1.13
7.34
2.0
2.3
umol/l
12.7
13.4
5.08
2618
15198
(3028707) Methadone [Presence] in Urine by Screen method
115
1272
0.59
7.31
2.5
2.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1039
5671
1.21
7.22
2.8
3.1
kpa
5.2
5.2
0.22
954
5196
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
389
1884
1.35
7.16
1.4
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
989
5383
1.21
7.08
2.8
3.0
mmol/l
2.2
2.0
1.21
777
4039
(3019060) Gas panel - Arterial blood
1058
5806
1.20
6.95
4.1
4.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
4473
27059
1.10
6.84
1.5
1.5
nmol/l
21.4
21.8
0.80
3685
22935
(3009343) pH of Capillary blood
1021
5596
1.20
6.80
2.8
3.0
ph
7.4
7.4
3.16
152
699
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
400
3436
0.76
6.79
1.2
1.3
u/ml
28.0
45.8
2.27
39
388
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
26
50
3.40
6.72
1.1
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
161
1606
0.65
6.59
1.1
1.1
iu/ml
59.5
7833.5
0.57
48
315
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
682
5470
0.81
6.57
1.6
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
719
3827
1.23
6.45
4.3
4.2
%
0.9
0.9
0.06
683
3586
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
729
3888
1.23
6.42
4.3
4.1
%
1.5
1.6
3.71
694
3647
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
387
3309
0.76
6.38
1.2
1.3
u/ml
1.1
6.2
2.85
27
254
(3027456) Digoxin [Moles/volume] in Serum or Plasma
400
1982
1.32
6.38
3.2
3.3
nmol/l
0.8
0.8
0.75
308
1572
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2631
15547
1.12
6.28
4.4
4.5
%
33.6
33.1
1.29
1652
10713
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
46
129
2.33
6.16
1.0
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
137
558
1.61
6.14
1.7
1.9
%
71.9
74.4
1.04
129
534
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
134
543
1.62
6.13
1.7
1.8
%
12.4
14.3
1.03
39
280
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
483
3987
0.79
6.05
1.1
1.1
u/ml
4.0
6.6
1.21
63
484
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
665
3543
1.23
5.94
3.0
3.2
mmol/l
25.3
25.2
1.03
604
3233
(3022313) Gas panel - Capillary blood
746
4023
1.22
5.93
2.9
3.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
33
507
0.42
5.91
1.2
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
212
1959
0.70
5.85
1.2
1.5
g/l
0.5
0.6
1.56
153
1489
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
258
2307
0.73
5.83
2.1
2.3
ug/min
55.7
62.0
0.18
128
1281
(3020874) Milk IgE Ab [Units/volume] in Serum
71
837
0.55
5.82
1.0
1.0
u/ml
0.3
1.0
0.93
21
219
(40761539) Cells [Type] in Urine sediment by Light microscopy
67
225
1.95
5.77
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
494
2560
1.27
5.66
1.4
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1251
7105
1.16
5.50
2.5
3.0
kpa
4.5
4.5
0.48
1201
6889
(3004716) Salmonella sp identified in Stool by Organism specific culture
891
6842
0.84
5.46
1.4
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
28
441
0.41
5.38
1.6
1.7
ug/l
9.3
8.6
0.46
28
441
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
19
354
0.35
5.35
1.7
2.4
au/ml
167.5
182.4
—
6
46
(3011412) CD3 cells [#/volume] in Blood
166
731
1.49
5.33
2.2
2.1
e9/l
1.1
1.3
0.97
110
399
(4010399)
1258
9381
0.87
5.27
1.4
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
70
803
0.57
5.25
1.1
1.0
u/ml
0.6
1.6
0.78
19
174
(3014148) Varicella zoster virus Ab [Titer] in Serum
137
1343
0.66
5.25
1.2
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
33
482
0.45
5.24
3.5
3.8
u/ml
39.4
1717.7
—
5
49
(3023183) Ammonium ion [Moles/volume] in Plasma
326
1618
1.32
5.23
2.2
2.8
umol/l
36.7
32.5
1.81
267
1390
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
16
26
4.02
5.19
1.1
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
34
90
2.47
5.19
1.4
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
23
49
3.07
5.16
1.2
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
135
574
1.54
5.12
2.0
1.9
%
38.0
47.0
1.79
21
103
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
91
351
1.70
5.10
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
91
351
1.70
5.10
1.2
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
190
1743
0.71
5.09
1.2
1.3
mmol/l
7.3
7.3
0.01
151
1280
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
307
2620
0.76
5.09
1.4
1.4
e6/l
909.8
2175.2
1.59
231
2156
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
307
2616
0.76
5.03
1.4
1.3
e6/l
20.3
36.3
1.01
212
2048
(1616796) Gas panel - Central venous blood
381
1944
1.28
5.00
3.3
3.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
30
76
2.58
5.00
1.3
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
476
3844
0.80
4.99
1.5
1.6
titre
122.3
296.5
3.88
20
203
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
1293
9585
0.87
4.98
2.4
2.4
au/ml
28.3
25.8
0.24
78
602
(3038177) Helicobacter pylori Ab [Presence] in Serum
272
2351
0.75
4.96
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
585
4617
0.82
4.90
1.6
1.7
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
130
554
1.54
4.90
1.4
1.6
mg/l
2.9
3.1
0.35
125
526
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
6055
37545
1.07
4.87
2.4
2.2
u/l
58.2
57.8
0.18
5508
34316
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
117
1163
0.66
4.84
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
54
644
0.55
4.70
1.1
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
41
124
2.16
4.70
1.3
1.1
mmol/l
2.0
1.8
0.43
32
53
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
136
1303
0.68
4.69
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
114
1130
0.66
4.67
1.2
1.2
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
33
92
2.34
4.56
1.3
1.2
mmol/l
2.2
2.1
0.03
23
43
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
151
1411
0.70
4.55
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
1632
11852
0.89
4.53
1.4
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
1182
8747
0.88
4.47
1.2
1.3
au/ml
59.2
47.2
0.80
52
372
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
97
982
0.64
4.42
1.2
1.2
titre
62.5
190.9
3.98
12
171
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
69
756
0.59
4.42
1.1
1.1
u/ml
2.4
7.4
—
6
123
(3017569) Oxygen content in Arterial blood
98
402
1.59
4.40
2.5
2.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
302
1523
1.30
4.39
2.2
1.9
mg/l
27.4
24.4
0.39
90
392
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
33
449
0.48
4.38
1.5
1.5
mmol/l
7.7
8.2
0.30
18
271
(3000012) Reticulocyte production index
117
501
1.53
4.37
1.5
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
62
695
0.58
4.35
1.0
1.0
u/ml
0.1
0.3
—
5
80
(3004616) Nuclear Ab [Presence] in Serum
218
1903
0.75
4.32
1.3
1.3
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
57
202
1.85
4.29
1.2
1.1
pmol/l
2.5
3.2
—
8
22
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
47
566
0.54
4.28
9.9
11.2
nmol/l
733.0
2606.3
0.54
47
543
(3044242) Glucose [Moles/volume] in Arterial blood
98
407
1.58
4.20
2.2
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
74
286
1.69
4.19
1.1
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
380
3080
0.80
4.19
1.8
1.8
u/l
2106.7
3604.2
0.73
122
1168
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
91
922
0.64
4.19
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
78
306
1.67
4.18
1.1
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
8
5
10.45
4.18
1.1
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
52
603
0.56
4.16
12.4
15.8
nmol/l
1326.2
4080.6
0.55
45
574
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
104
440
1.55
4.12
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
424
2248
1.24
4.10
2.0
2.0
g/l
126.6
129.0
1.20
277
1627
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
91
915
0.65
4.06
1.2
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
107
1038
0.67
4.00
1.5
1.8
umol/l
7.7
6.9
0.14
74
751
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
695
3873
1.18
4.00
1.5
1.7
g/l
1.7
1.6
1.24
570
3301
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
148
679
1.43
3.97
1.7
1.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
139
1283
0.71
3.96
1.1
1.4
g/l
6.5
6.7
0.26
89
919
(3009214) Lutropin [Units/volume] in Serum or Plasma
334
1731
1.26
3.96
1.2
1.2
u/l
22.5
18.6
3.51
284
1388
(3007461) Platelets [#/volume] in Blood
21215
137649
1.14
3.96
26.2
16.5
e9/l
260.0
265.7
33.86
20828
133917
(3039162) Centromere protein B Ab [Units/volume] in Serum
239
2031
0.77
3.94
1.2
1.3
u/ml
67.5
57.3
0.20
15
156
(3024139) IgG subclass 3 [Mass/volume] in Serum
139
1281
0.71
3.93
1.1
1.4
g/l
0.4
0.4
0.38
90
921
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
422
2248
1.23
3.93
2.5
2.8
mg/l
1.4
1.5
2.40
378
2048
(3028192) IgG subclass 2 [Mass/volume] in Serum
139
1280
0.71
3.92
1.1
1.4
g/l
2.7
2.9
0.74
90
917
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
149
0.26
3.89
1.2
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
80
323
1.62
3.87
2.0
2.4
%
42.6
46.6
0.73
25
122
(4062490)
140
1285
0.71
3.87
1.1
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
122
1146
0.69
3.86
1.3
1.3
u/ml
2.7
1.1
0.38
45
493
(3009466) Valproate [Moles/volume] in Serum or Plasma
190
1661
0.74
3.85
5.0
5.3
umol/l
367.7
381.3
0.65
162
1458
(3008295) Osmolality of Serum or Plasma
212
1040
1.33
3.81
1.3
1.5
mosm/kgh2o
274.6
276.2
0.47
158
787
(3047181) Lactate [Moles/volume] in Blood
535
2928
1.20
3.80
4.9
4.8
mmol/l
1.2
1.3
0.12
482
2575
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
12
20
3.92
3.80
1.0
1.1
ng/l
3300.3
8885.3
—
7
9
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
31
92
2.20
3.78
1.0
2.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
98
419
1.53
3.74
2.3
2.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
108
1031
0.68
3.74
1.2
1.4
—
6124.4
—
0
9
(3023420) DNA double strand Ab [Units/volume] in Serum
185
1615
0.75
3.73
1.3
1.6
iu/ml
23.0
36.4
—
7
70
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1163
6767
1.13
3.69
1.3
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
66
257
1.68
3.69
1.2
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
369
1953
1.24
3.68
5.8
5.6
mmol/l
10.5
11.1
3.54
335
1746
(3018572) Chloride [Moles/volume] in Blood
369
1954
1.24
3.66
5.8
5.6
mmol/l
105.4
104.8
1.67
335
1747
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
130
1194
0.71
3.64
1.7
1.5
%
34.9
34.6
0.04
77
697
(3042733) HLA Ab [Presence] in Serum
18
285
0.41
3.64
4.8
5.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1540
11069
0.90
3.58
1.4
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
382
2037
1.23
3.56
1.4
1.4
mmol/l
60.3
62.2
0.37
290
1618
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
263
2176
0.79
3.54
1.5
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
271
2234
0.79
3.54
1.2
1.3
titre
80.0
94.6
—
6
41
(3004588) Protein electrophoresis panel - Serum or Plasma
1178
6879
1.13
3.54
2.2
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
564
3125
1.18
3.52
3.2
3.9
mmol/l
1.4
1.3
0.35
559
3067
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
353
0.48
3.51
1.2
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
46
524
0.57
3.51
1.1
1.1
miu/ml
1164.2
1562.6
2.22
46
524
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
251
2084
0.78
3.49
1.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
335
1772
1.24
3.39
1.7
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
240
1220
1.29
3.39
2.3
2.2
—
—
—
0
0
(4198724)
25
338
0.48
3.36
1.0
2.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
21216
137742
1.13
3.36
26.1
16.5
pg
30.3
30.2
54.42
21017
135668
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
100
946
0.69
3.35
1.2
1.1
mg/l
41.5
38.6
0.14
90
783
(3008536) Aspergillus sp Ab [Presence] in Serum
38
129
1.93
3.33
2.7
1.5
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
44
157
1.83
3.33
1.1
1.4
g/l
16.3
10.4
3.56
34
107
(3009445) Proteinase 3 Ab [Units/volume] in Serum
643
4851
0.86
3.29
1.4
1.5
u/ml
24.7
14.7
0.42
11
106
(3024731) MCV [Entitic volume]
21216
137752
1.12
3.29
26.1
16.5
fl
91.8
90.9
160.09
21018
135674
(3021901) Oxygen saturation in Capillary blood
299
1568
1.25
3.28
2.5
2.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
18
44
2.67
3.28
1.1
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
160
773
1.35
3.24
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
35
117
1.96
3.21
1.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
21216
137766
1.12
3.20
26.2
16.5
e12/l
4.3
4.4
307.65
20790
133642
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
92
875
0.69
3.19
1.1
1.1
—
—
—
0
0
(4027681)
73
725
0.66
3.16
1.4
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
21217
137779
1.12
3.16
26.2
16.6
e9/l
6.2
6.5
11.87
20795
133641
(3019977) pH of Arterial blood
105
474
1.45
3.15
2.8
2.6
ph
7.4
7.4
0.33
50
152
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
48
521
0.60
3.09
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
2205
13383
1.08
3.07
1.3
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1467
8748
1.10
3.04
2.5
2.7
ng/l
165.0
165.4
0.01
1342
7934
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
416
3225
0.84
3.02
1.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
17442
112471
1.06
3.01
18.5
12.2
%
38.5
39.3
28.27
12563
82630
(3028626) Oxygen [Partial pressure] in Capillary blood
344
1852
1.22
2.99
2.4
2.5
kpa
8.2
8.2
0.18
317
1722
(3000963) Hemoglobin [Mass/volume] in Blood
21216
137799
1.12
2.98
26.3
16.6
g/l
130.0
133.5
307.65
21023
135746
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
30
366
0.53
2.97
1.3
2.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
472
3611
0.85
2.94
1.2
1.2
titre
511.5
1024.0
2.32
20
165
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
27
338
0.52
2.92
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
27
338
0.52
2.92
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
27
338
0.52
2.92
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
27
338
0.52
2.92
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
37
422
0.57
2.91
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
339
2666
0.83
2.90
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
139
670
1.36
2.90
1.7
1.7
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
9
158
0.37
2.89
2.0
1.7
mg/l
1.6
1.6
—
9
135
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
515
2886
1.17
2.88
3.0
1.6
mg/l
39.0
34.0
0.32
404
2332
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
770
4442
1.14
2.88
2.1
2.8
%
0.7
0.7
0.14
736
4235
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
149
0.35
2.88
1.3
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
11
191
0.38
2.83
1.2
1.1
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
24
73
2.15
2.83
1.3
1.2
u/l
34.8
560.9
0.51
19
42
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
3888
26680
0.94
2.83
1.6
1.6
pmol/l
46204021.8
40060760.1
0.22
3095
22219
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
159
786
1.32
2.82
1.3
1.4
umol/l
11.2
11.3
0.03
154
746
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
68
667
0.66
2.82
1.0
1.1
u/l
1.1
1.1
0.09
42
292
(44816559) Phosphatidylethanol [Mass/volume] in Blood
227
1851
0.80
2.79
1.2
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
992
5826
1.12
2.77
2.5
3.1
g/l
124.5
128.9
9.14
970
5688
(40768446) Kidney Pathology biopsy report
27
331
0.53
2.75
1.4
1.7
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
43
464
0.60
2.75
2.4
2.9
umol/l
27.3
27.9
0.12
30
357
(3037121) Protein [Mass/volume] in Urine
584
3320
1.15
2.72
2.6
2.5
g/l
0.2
0.3
7.37
189
905
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
333
2604
0.83
2.71
1.2
1.2
mmol/l
3.6
3.7
2.00
314
2441
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
16
233
0.45
2.71
2.5
2.0
umol/l
13.6
18.2
1.41
16
233
(3035350) Ketones [Presence] in Urine by Test strip
9105
61056
0.96
2.67
3.7
3.8
estimate
0.0
0.0
0.11
1767
10452
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
551
3125
1.16
2.66
1.9
2.1
ug/l
335.0
517.2
1.21
491
2876
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
101
911
0.72
2.65
1.2
1.1
mg/l
291.5
244.2
0.56
92
793
(3020891) Body temperature
648
3720
1.14
2.64
3.7
4.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
23
71
2.12
2.63
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
36
131
1.80
2.63
6.7
1.3
u/l
44.1
41.1
0.21
12
53
(3046861) Legionella sp Ag [Presence] in Urine
14
34
2.69
2.61
1.2
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
55
553
0.65
2.60
1.4
1.6
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
33
375
0.57
2.60
1.0
1.1
u/ml
0.3
0.7
0.74
16
185
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
383
2946
0.85
2.60
1.3
1.3
mg/l
549.2
516.7
0.45
365
2797
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5416
36739
0.95
2.57
1.9
2.0
u/l
160.4
161.8
0.04
5028
34248
(3034860) Kappa light chains.free [Mass/volume] in Serum
513
2903
1.16
2.57
3.0
1.6
mg/l
45.4
38.4
0.35
402
2353
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
123
1071
0.75
2.57
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
449
2516
1.17
2.56
2.1
2.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
65
280
1.52
2.52
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
4786
32548
0.95
2.50
4.1
4.3
estimate
0.0
0.0
3.22
1756
10640
(3047189) Immunofixation for 24 hour Urine
61
260
1.53
2.49
2.1
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
139
1184
0.77
2.49
1.2
1.2
u/ml
10.2
50.3
7.55
16
103
(40757373) Influenza virus identified in Isolate
44
173
1.66
2.48
1.2
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
139
1183
0.77
2.47
1.2
1.2
u/ml
68.6
70.4
—
10
63
(3027273) Bicarbonate [Moles/volume] in Venous blood
795
4647
1.12
2.46
2.8
3.0
mmol/l
25.7
25.7
0.21
777
4510
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
385
2942
0.85
2.43
1.2
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
572
3279
1.14
2.41
2.1
1.5
g/l
0.6
0.4
0.83
477
2789
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
20
255
0.51
2.36
1.3
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
75
693
0.71
2.32
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
194
1571
0.80
2.31
1.4
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
478
3577
0.87
2.30
1.2
1.2
titre
148.3
145.8
0.02
41
304
(3035320) C reactive protein [Mass/volume] in Body fluid
174
900
1.26
2.27
2.2
2.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
128
636
1.32
2.27
1.2
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
200
1052
1.24
2.26
5.0
7.9
mmol/l
7.1
7.5
0.66
169
853
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
14
37
2.47
2.26
1.3
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
202
1624
0.81
2.25
1.6
1.6
%
56.1
52.3
0.71
133
995
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
491
2801
1.15
2.25
3.0
1.6
ratio
3.3
1.4
0.59
28
237
(3014271) Vancomycin [Susceptibility]
104
502
1.35
2.24
2.9
3.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
5
6.53
2.24
1.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
734
5334
0.90
2.22
2.0
2.1
u/l
42.1
40.1
2.02
647
4791
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
209
1671
0.82
2.22
1.1
1.2
u/ml
278.2
289.8
0.21
132
1105
(3020191) Ethanol [Moles/volume] in Serum or Plasma
81
730
0.72
2.18
1.2
1.5
promille
1.1
1.3
0.29
66
546
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
147
1218
0.79
2.16
1.1
1.1
—
76.4
—
0
17
(3043409) Potassium [Moles/volume] in Arterial blood
479
2737
1.15
2.16
3.3
4.2
mmol/l
3.8
3.8
0.05
450
2591
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
257
2006
0.83
2.13
1.1
1.1
u/ml
3.0
3.1
0.04
113
966
(3022689) Creatine [Moles/volume] in Urine
36
377
0.62
2.11
1.4
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
25
286
0.57
2.08
1.3
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
232
1823
0.83
2.08
1.5
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
533
3078
1.13
2.07
2.0
1.4
g/l
38.0
38.1
0.15
441
2583
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
23
79
1.90
2.05
3.0
1.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
83
736
0.74
2.04
1.7
2.3
ml
619.6
634.4
0.13
49
532
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
536
3942
0.89
2.02
1.4
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
112
557
1.31
2.02
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
73
658
0.72
2.00
1.3
1.5
%
2.9
4.8
0.86
20
129
(21494890) Protein electrophoresis panel - 24 hour Urine
147
759
1.27
2.00
1.9
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
176
1414
0.81
1.99
1.2
1.2
u/l
26.6
22.6
0.39
144
1228
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
98
845
0.76
1.99
1.0
1.0
ng/l
40.9
46.5
0.67
75
597
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
459
3405
0.88
1.99
2.1
2.2
mg/l
10.5
10.6
0.12
423
3153
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
136
1124
0.79
1.99
1.2
1.2
u/ml
2.0
9.2
—
10
86
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
27
99
1.78
1.99
2.0
2.1
—
—
—
0
0
(44813793)
134
1109
0.79
1.98
1.1
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
106
0.37
1.95
1.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
410
3057
0.87
1.93
1.4
1.5
iu/ml
14.9
20.1
—
9
99
(3025577) Chromium [Mass/volume] in Blood
72
646
0.73
1.93
2.0
2.1
ug/l
2.2
2.9
1.35
61
545
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
461
2652
1.14
1.92
2.1
1.4
g/l
0.0
0.0
0.00
411
2417
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
166
874
1.24
1.92
3.6
3.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
1211
8526
0.92
1.91
2.8
2.4
g/l
10.1
10.5
2.70
1097
7767
(40760888) Immunoglobulin light chains.free panel - Serum
371
2104
1.15
1.90
3.2
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
95
816
0.76
1.90
1.2
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
60
553
0.71
1.90
1.7
2.1
min
514.0
498.2
0.63
38
436
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
466
2686
1.14
1.89
2.0
1.4
g/l
0.0
0.0
0.04
412
2426
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
150
1217
0.80
1.88
1.1
1.1
—
45.5
—
0
15
(40758292) HTLV I+II Ab panel - Serum
19
63
1.97
1.88
1.3
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
389
2217
1.15
1.87
2.6
2.7
mmol/l
25.8
25.2
1.71
329
1949
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
39
162
1.57
1.85
1.1
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
24
267
0.59
1.84
1.1
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
99
840
0.77
1.82
1.0
1.0
ng/l
745.0
741.9
0.02
75
581
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
503
2922
1.13
1.82
2.0
1.4
g/l
0.0
0.0
0.49
447
2654
(3026470) Cobalt [Mass/volume] in Blood
76
669
0.74
1.82
2.0
2.1
ug/l
3.2
4.1
0.88
66
595
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
39
163
1.56
1.81
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
39
163
1.56
1.81
1.1
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
14534
96128
0.96
1.81
3.8
4.2
mm/h
13.9
11.9
50.98
13250
89579
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
98
831
0.77
1.80
1.0
1.0
ng/l
654.1
342.6
0.43
75
599
(3041096) Erythrocytes [Presence] in Urine by Automated
4894
33016
0.96
1.78
3.6
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
72
636
0.74
1.77
1.3
1.4
nmol/l
1.3
1.2
0.07
54
509
(1761482) Bacteria [#/volume] in Urine by Culture
489
2843
1.13
1.76
4.6
4.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
22
79
1.82
1.75
1.4
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
35
144
1.59
1.74
1.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
34
343
0.65
1.74
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
263
2006
0.85
1.73
1.3
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
11
152
0.47
1.72
1.2
2.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
523
3808
0.89
1.71
1.8
1.9
iu/l
21.5
13.8
0.18
195
1494
(4094501)
478
3498
0.89
1.71
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
4318
29181
0.96
1.71
3.4
3.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
3484
21877
1.05
1.70
1.7
1.7
nmol/l
1158.8
1199.4
1.61
2504
16528
(3010838) Calcium [Moles/time] in 24 hour Urine
141
741
1.24
1.70
1.6
1.6
mmol/24h
5.7
5.3
0.16
15
71
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
229
1763
0.85
1.70
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
7916
50538
1.04
1.70
1.9
1.9
pmol/l
100.1
100.5
0.25
3578
23723
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
10
26
2.51
1.69
1.0
1.0
u/l
354.7
179.2
—
10
18
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
729
4343
1.10
1.68
3.5
3.6
%
46.9
47.7
0.34
722
4299
(3036312) Salmon IgE Ab [Units/volume] in Serum
5
90
0.36
1.66
1.0
1.1
u/ml
0.0
0.5
—
5
68
(3030981) Hyaline casts [#/volume] in Urine by Automated count
866
5204
1.09
1.66
2.4
2.4
e6/l
0.3
0.3
0.11
842
4967
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
77
666
0.75
1.66
11.6
12.3
mmol/l
0.7
0.6
0.66
68
606
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
494
3598
0.89
1.64
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
28
111
1.65
1.62
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
45
421
0.70
1.60
1.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
191
1044
1.20
1.59
2.1
2.1
u/field
3.0
2.8
0.15
79
416
(3024928) Oxygen saturation in Venous blood
330
1885
1.15
1.59
2.0
3.5
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
17
58
1.91
1.59
1.0
1.1
u/field
0.9
1.4
1.34
11
38
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
89
749
0.78
1.58
1.2
1.3
mmol/l
5.8
5.8
0.19
83
707
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
27
107
1.65
1.58
1.0
1.1
—
—
—
0
0
(3015736) pH of Urine
7071
47271
0.97
1.57
3.4
3.6
ph
5.8
5.6
—
9
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
267
2016
0.86
1.57
1.1
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
152
814
1.22
1.57
1.3
1.3
titre
631.1
474.3
—
9
54
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
17
197
0.56
1.56
1.1
1.1
u/ml
1.5
0.2
0.40
11
121
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
23
246
0.61
1.55
1.0
1.0
ug/l
86.6
80.4
0.37
17
203
(3051593) INR in Capillary blood by Coagulation assay
87
437
1.30
1.54
7.4
9.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
53
478
0.72
1.53
1.6
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
92
767
0.78
1.53
1.5
1.4
u/l
5.3
5.3
0.01
69
640
(3006653) Thiamine [Moles/volume] in Blood
68
590
0.75
1.53
1.2
1.4
nmol/l
133.7
133.1
0.03
68
590
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
65
567
0.75
1.52
1.4
1.4
umol/l
2.7
3.7
2.15
60
520
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
621
3695
1.10
1.51
1.9
1.4
g/l
3.2
3.0
1.87
478
2828
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
148
1169
0.83
1.50
1.1
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
31
307
0.66
1.50
1.2
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
148
795
1.22
1.50
1.3
1.3
titre
37.3
52.7
0.65
15
64
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
105
859
0.80
1.49
2.3
2.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
148
1168
0.83
1.49
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
148
1168
0.83
1.49
1.1
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
27
109
1.62
1.48
2.0
2.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
115
930
0.81
1.48
1.2
1.3
mmol/l
11.1
11.8
0.31
33
219
(3011335) Digoxin [Mass/volume] in Serum or Plasma
20
75
1.74
1.43
2.7
2.4
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
18
2.54
1.40
1.1
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
611
3649
1.10
1.40
2.0
1.4
g/l
9.8
10.1
0.68
503
3010
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
148
1159
0.83
1.39
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
148
1158
0.83
1.38
1.1
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
14
47
1.95
1.38
5.9
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
196
1091
1.17
1.37
1.1
1.2
nmol/l
340.4
385.3
2.38
170
939
(3022493) Free Hemoglobin [Mass/volume] in Plasma
73
365
1.31
1.36
1.1
4.0
mg/l
7934.3
509.5
0.99
54
247
(40759836) Histone Ab [Presence] in Serum by Immunoblot
148
1156
0.84
1.36
1.1
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
651
3905
1.09
1.36
2.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
44
203
1.42
1.35
1.9
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
9326
61950
0.97
1.35
3.7
3.8
estimate
0.0
0.0
0.77
1780
10573
(4211845)
122
651
1.23
1.35
4.0
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
9236
61360
0.97
1.34
5.0
5.1
estimate
0.0
0.0
3.74
1757
10600
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
305
1758
1.13
1.34
1.1
1.1
%
125.3
124.3
0.21
275
1572
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
650
3904
1.09
1.33
2.0
1.4
g/l
3.8
3.7
0.55
463
2747
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
9
27
2.18
1.32
12.1
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
651
3913
1.09
1.31
2.0
1.4
g/l
7.6
7.5
1.33
495
2871
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
5
11
2.97
1.29
1.0
1.7
umol/l
4372.0
3139.8
—
5
11
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
10
30
2.18
1.29
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
425
3071
0.90
1.29
1.7
1.6
e6/l
16435.1
10267.3
1.48
310
2239
(3045414) Leukocytes [Presence] in Urine
862
6038
0.93
1.29
1.9
1.8
—
—
—
0
0
(3036603) Volume of Urine
135
732
1.21
1.29
1.4
1.4
ml
1917.1
1857.2
0.16
30
163
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
30
288
0.68
1.28
1.4
1.2
—
—
—
0
0
(44806071)
16
177
0.59
1.28
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
13
152
0.56
1.27
1.1
1.1
umol/24h
1.7
1.6
0.34
13
152
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
60
296
1.32
1.25
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
124
669
1.21
1.25
1.9
1.8
u/field
1.7
2.2
0.56
85
453
(3044290) Cell count panel - Cerebral spinal fluid
334
2439
0.89
1.24
1.3
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
32
301
0.69
1.23
1.1
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
97
0.47
1.23
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
1437
8906
1.06
1.23
3.1
2.6
e9/l
3.8
3.9
1.15
1128
6882
(3027923) C peptide [Moles/volume] in Serum or Plasma
70
583
0.78
1.21
1.3
1.6
nmol/l
1.4
1.3
0.22
50
475
(3028026) IgM [Mass/volume] in Serum or Plasma
953
6634
0.94
1.21
1.8
1.6
g/l
1.3
1.3
0.00
853
6048
(40762814) Titanium [Mass/volume] in Blood
21
214
0.64
1.21
1.9
2.3
ug/l
5.2
3.9
—
10
88
(3024932) HLA-DR beta [Type]
26
253
0.67
1.20
1.3
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
85
0.46
1.20
4.7
6.8
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
23
0.00
1.20
0.0
1.4
—
—
—
0
0
(3009883) Potato IgE Ab [Units/volume] in Serum
0
23
0.00
1.20
0.0
1.0
—
0.2
—
0
15
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
13
149
0.57
1.20
1.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
14
157
0.58
1.19
12.9
8.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
48
231
1.36
1.19
1.5
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
44
209
1.38
1.18
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
52
254
1.34
1.17
1.1
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
102
811
0.82
1.17
1.7
1.9
nmol/l
15.8
16.8
0.61
95
763
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
40
358
0.73
1.17
1.9
2.4
nmol/l
181.5
162.1
0.58
34
317
(4024509)
232
1328
1.14
1.17
1.7
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
44
210
1.37
1.15
1.7
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
35
319
0.72
1.15
1.1
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
10
122
0.54
1.15
1.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
92
0.50
1.13
1.4
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
417
2987
0.91
1.11
2.2
2.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
142
787
1.18
1.10
1.2
1.2
mmol/l
36.1
32.3
1.18
128
645
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
123
954
0.84
1.10
1.1
1.1
mg/l
313.5
612.2
0.47
106
852
(3036670) Protein [Mass/volume] in Synovial fluid
67
343
1.28
1.10
1.4
1.3
g/l
38.7
38.4
0.06
36
182
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
160
0.61
1.07
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
52
441
0.77
1.07
1.1
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
40
352
0.74
1.07
24.3
25.3
ug/l
114.2
116.2
0.07
33
287
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
33
152
1.42
1.07
1.0
1.1
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
14
52
1.76
1.07
1.1
1.1
mg/l
9.6
13.6
0.52
14
44
(3052592) Norovirus Ag [Presence] in Stool
40
191
1.37
1.06
1.4
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
154
1167
0.86
1.05
1.6
1.4
e6/l
145734.1
95638.3
0.39
99
786
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
20
83
1.57
1.04
2.6
3.2
mmol/l
0.7
0.9
0.28
15
56
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
107
582
1.20
1.04
1.1
1.0
%
101.8
96.3
1.27
88
450
(3002621) Streptococcal DNAse B [Units/volume] in Serum
18
73
1.61
1.03
1.1
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
1604
10935
0.95
1.01
1.1
1.2
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
20
0.00
1.01
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
28
258
0.71
1.01
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
233
1708
0.89
0.99
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
84
666
0.82
0.98
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
4244
27052
1.03
0.98
3.8
4.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
46
390
0.77
0.97
1.0
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
115
0.57
0.97
1.3
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
15
59
1.66
0.96
1.0
1.1
iu/ml
20.7
9.0
—
6
9
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
710
4938
0.94
0.94
1.7
1.7
mg/l
2.5
3.3
3.11
544
3528
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
72
576
0.82
0.93
1.1
1.2
%
57.5
56.6
0.03
13
60
(3025018) Bordetella pertussis Ab [Titer] in Serum
114
873
0.85
0.92
1.3
1.3
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
18
2.18
0.91
1.0
1.1
%
2.2
1.6
—
6
18
(3012565) Volume of 24 hour Urine
92
501
1.20
0.91
1.8
1.7
ml
1900.1
1948.7
0.17
81
453
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
5278
35165
0.97
0.91
1.6
1.7
mmol/l
1.3
1.3
0.03
4355
29763
(3013166) Neutrophils/100 leukocytes in Synovial fluid
42
356
0.77
0.90
1.9
1.4
%
48.7
49.6
0.05
30
303
(3021788) Differential panel - Synovial fluid
325
2324
0.91
0.89
1.5
1.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
143
811
1.15
0.89
1.5
1.8
mmol/l
6.9
6.7
0.24
98
547
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
12446
82076
0.98
0.89
3.0
2.9
u/l
51.2
39.1
25.01
11461
76592
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
66
1.58
0.88
1.1
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
105
582
1.18
0.87
1.5
1.8
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
6
77
0.51
0.85
1.0
1.0
u/ml
0.0
0.2
—
6
67
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
134
0.63
0.84
4.6
5.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
207
1509
0.89
0.84
1.1
1.1
g/l
1.5
1.5
1.87
188
1352
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
129
969
0.87
0.84
1.1
1.1
iu/ml
6.5
8.6
0.60
34
229
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
107
597
1.17
0.83
3.9
1.7
%
141.6
133.8
0.48
102
560
(3006462) Nitrate [Presence] in Urine
107
598
1.17
0.82
4.1
3.1
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
17
0.00
0.81
0.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
18
0.00
0.80
0.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
80
437
1.20
0.80
1.3
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
83
0.55
0.80
3.7
2.0
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
11
42
1.71
0.79
1.7
1.3
u/field
1.0
1.2
—
5
32
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
19
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
19
0.00
0.79
0.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
1250
8504
0.96
0.77
3.4
3.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
23
207
0.73
0.77
1.3
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
35
295
0.77
0.75
1.3
1.3
nmol/l
96.2
130.6
1.21
23
197
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
24
1.91
0.75
2.7
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
53
280
1.24
0.74
1.1
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
73
0.54
0.74
1.0
1.0
—
—
—
0
0
(4133840)
33
279
0.77
0.73
1.2
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
16
2.04
0.73
1.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
79
436
1.18
0.73
1.2
1.1
%
110.5
116.5
0.82
71
390
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
29
142
1.33
0.72
1.2
1.3
ng/l
96.8
69.6
0.25
18
94
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
12
49
1.60
0.70
2.0
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
14
135
0.68
0.70
1.1
1.2
—
—
—
0
0
(4015189)
36
298
0.79
0.69
1.9
2.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
53
284
1.22
0.67
1.1
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
18
164
0.72
0.67
1.8
2.9
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
5
18
1.81
0.66
1.0
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
5
18
1.81
0.66
1.0
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
18
1.81
0.66
1.0
1.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
18
1.81
0.66
1.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
17
156
0.71
0.66
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
81
453
1.17
0.66
2.1
2.5
mmol/l
9.6
9.0
0.76
64
326
(3025130) Human papilloma virus identified in Specimen
404
2469
1.07
0.65
1.5
1.7
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
34
281
0.79
0.65
1.3
1.3
mg/l
0.8
17.6
0.49
25
207
(3023410) Appearance of Cerebral spinal fluid
163
1182
0.90
0.65
1.5
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
118
872
0.88
0.65
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
111
823
0.88
0.65
1.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
45
1.60
0.64
9.1
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
12
117
0.67
0.64
11.3
11.3
mmol/l
4.4
4.5
0.04
12
117
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
71
543
0.85
0.63
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
109
0.66
0.63
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
11
109
0.66
0.63
1.1
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
21
184
0.75
0.62
1.1
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
5
19
1.72
0.62
1.0
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
15
67
1.46
0.62
1.5
1.7
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
14
0.00
0.62
0.0
1.2
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
14
0.00
0.62
0.0
1.2
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
14
0.00
0.62
0.0
1.9
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
15
0.00
0.61
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
68
518
0.86
0.59
1.2
1.2
g/l
0.3
0.3
0.36
53
413
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
52
283
1.20
0.59
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
57
1.49
0.59
1.1
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
62
475
0.85
0.58
1.2
1.2
%
110.3
114.1
0.48
51
419
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
57
0.57
0.58
1.0
1.5
umol/24h
355.6
290.9
—
5
57
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
243
1716
0.92
0.58
1.2
1.3
u/ml
22.2
25.6
—
5
30
(21494567) Legionella sp IgM Ab [Presence] in Serum
14
63
1.45
0.57
1.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
14
63
1.45
0.57
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
1097
7421
0.96
0.57
1.3
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
303
2117
0.93
0.55
1.1
1.1
au/ml
7.0
12.0
1.07
12
107
(3033923) Metanephrine [Moles/time] in 24 hour Urine
41
324
0.83
0.55
1.1
1.1
umol/24h
0.5
0.7
1.26
13
152
(3020717) Zinc [Moles/volume] in Serum or Plasma
94
694
0.88
0.54
1.5
1.4
umol/l
36.2
24.5
2.36
89
652
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
211
1270
1.09
0.54
1.1
1.1
%
98.1
95.4
0.71
197
1189
(3000060) B lymphocytes [#/volume] in Blood
28
230
0.79
0.54
1.4
1.9
e6/l
2170.0
169.6
0.50
11
142
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
93
536
1.13
0.54
1.5
1.4
pmol/l
15.4
14.8
0.57
75
449
(40768797) Stomach Pathology biopsy report
2773
18482
0.98
0.54
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
92
530
1.13
0.54
2.5
2.3
e6/l
608.2
1011.1
1.31
43
255
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
25
1.57
0.53
1.0
1.0
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
12
53
1.48
0.53
1.4
1.5
u/l
0.0
0.1
—
6
16
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
76
568
0.87
0.53
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
47
257
1.19
0.52
1.0
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
75
427
1.15
0.52
1.1
1.1
%
94.6
96.0
0.10
38
186
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
224
1578
0.93
0.52
1.2
1.4
u/ml
121.2
118.5
0.08
54
377
(3023419) Bacteria identified in Sputum by Culture
199
1198
1.09
0.52
2.5
2.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
79
452
1.14
0.51
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1018
6878
0.97
0.51
1.2
1.4
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
16
76
1.38
0.50
1.0
1.1
s
34.9
36.6
0.78
16
64
(3035611) Eosinophils/100 leukocytes in Synovial fluid
16
76
1.38
0.50
2.6
1.8
%
0.2
0.3
—
10
58
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
76
435
1.14
0.50
1.1
1.1
%
91.1
93.8
0.30
38
185
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
7
29
1.58
0.50
1.1
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
47
259
1.19
0.49
1.1
1.3
mu/l
90.8
58.2
0.35
32
193
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
43
235
1.20
0.49
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
76
436
1.14
0.49
1.4
1.6
umol/l
32.9
30.5
1.35
71
420
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
11
102
0.70
0.48
1.0
1.1
—
—
—
0
0
(3025315) Body weight
8
78
0.67
0.47
4.0
4.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
114
673
1.11
0.46
1.8
1.6
g/24h
0.3
1.1
—
6
47
(4306422)
299
1838
1.06
0.46
1.1
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
45
249
1.18
0.46
4.7
5.7
mmol/l
24.9
25.6
0.62
38
230
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
32
1.43
0.46
1.0
1.1
nmol/l
372.6
316.8
—
7
32
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
7
32
1.43
0.46
2.4
2.0
—
—
—
0
0
(3001729) Color of Synovial fluid
19
95
1.31
0.45
2.3
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
123
881
0.91
0.44
1.5
1.3
nmol/l
1.5
1.5
0.21
110
792
(3020123) Porphyrins [Interpretation] in Serum or Plasma
9
85
0.69
0.44
1.0
1.1
—
—
—
0
0
(44806420)
38
294
0.84
0.44
2.1
2.3
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
8
36
1.45
0.43
2.6
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
354
2195
1.05
0.42
1.4
1.6
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
10
0.00
0.42
0.0
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1471
9377
1.03
0.42
3.0
3.0
pmol/l
4.4
4.5
0.09
1308
8240
(3013336) Amino acids [Identifier] in Serum or Plasma
0
11
0.00
0.42
0.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
86
625
0.90
0.42
1.4
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
77
448
1.12
0.42
1.7
1.6
ug/l
0.4
0.4
0.19
56
289
(3032352) Blasts [#/volume] in Cerebral spinal fluid
10
45
1.45
0.42
1.7
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
38
1.38
0.41
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
117
836
0.91
0.41
1.2
1.1
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
12
0.00
0.41
0.0
1.3
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
12
0.00
0.41
0.0
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
283
1955
0.94
0.41
1.5
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
50
283
1.15
0.41
2.4
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
50
283
1.15
0.41
2.4
2.6
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
50
374
0.87
0.39
1.1
1.2
%
20.4
22.1
—
10
67
(3044927) Protein electrophoresis panel - Urine
144
1016
0.93
0.39
1.2
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
872
5527
1.03
0.38
1.1
1.1
u/ml
1.2
2.8
0.62
13
88
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2359
15143
1.02
0.38
6.7
5.9
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
9
44
1.34
0.38
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
99
709
0.91
0.38
1.7
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
249
1721
0.94
0.38
1.2
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
68
396
1.12
0.38
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
223
1546
0.94
0.37
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
14
69
1.33
0.37
1.7
2.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
80
0.73
0.36
1.1
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
23
123
1.22
0.35
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
13
110
0.77
0.35
1.1
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
106
752
0.92
0.34
1.1
1.1
nmol/l
2.0
4.6
0.81
13
143
(4212803)
15
76
1.29
0.34
1.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
16
82
1.27
0.34
1.1
1.1
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
11
53
1.36
0.34
1.1
1.3
mmol/l
24.1
23.7
—
5
33
(3019768) Coxiella burnetii Ab [Presence] in Serum
11
53
1.36
0.34
1.2
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
21
166
0.83
0.33
1.5
1.4
%
52.1
47.8
—
8
95
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
146
1019
0.94
0.32
1.1
1.1
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
7
33
1.39
0.32
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
28
155
1.18
0.31
1.5
2.3
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
7
35
1.31
0.31
1.1
3.6
umol/l
309.6
266.1
—
7
35
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1292
8606
0.98
0.30
2.1
2.2
ug/l
4.5
6.1
4.33
1053
7348
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
154
946
1.06
0.29
1.3
1.5
u/ml
24.0
22.5
0.10
22
196
(3019420) Tryptase [Mass/volume] in Serum or Plasma
94
664
0.92
0.29
1.4
1.5
ug/l
8.1
8.3
0.06
87
588
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
16
84
1.24
0.29
1.1
1.1
u/l
7.6
10.9
0.45
16
84
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
14
114
0.80
0.29
4.6
7.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
32
181
1.15
0.29
1.1
1.1
—
1.6
—
0
8
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
264
1803
0.96
0.29
1.2
1.2
u/ml
3.0
3.8
1.06
98
746
(3016018) Differential panel - Cerebral spinal fluid
203
1259
1.05
0.29
1.3
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
31
233
0.87
0.28
1.7
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
11
92
0.78
0.28
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
98
594
1.08
0.28
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1747
11234
1.02
0.27
2.3
1.8
nmol/l
384.6
366.1
3.15
1610
10223
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
66
471
0.91
0.27
2.1
1.9
umol/l
265.9
129.6
0.99
39
255
(3000570) Elastase.pancreatic [Mass/mass] in Stool
527
3544
0.97
0.27
1.3
1.4
ug/g
278.0
299.1
1.57
313
1964
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
35
259
0.88
0.27
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
170
1053
1.05
0.26
1.4
1.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
112
781
0.94
0.26
1.4
1.5
umol/l
57.1
63.8
—
7
60
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
78
470
1.08
0.26
1.1
1.1
ng/l
324.2
517.7
0.20
23
98
(3035933) Granulocytes/100 leukocytes in Blood
46
270
1.11
0.25
2.4
1.9
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
21
116
1.18
0.25
3.4
2.4
umol/l
33.1
40.8
0.72
16
99
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
272
1707
1.04
0.25
1.3
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
49
289
1.11
0.25
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
104
1.19
0.25
1.1
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
39
227
1.12
0.25
1.8
1.6
mmol/l
1.7
1.1
0.27
34
217
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
12
62
1.26
0.25
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
25
141
1.16
0.24
1.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
70
422
1.08
0.24
2.3
2.4
—
—
—
0
0
(4146454)
193
1204
1.05
0.24
2.7
2.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
35
203
1.13
0.24
1.0
1.3
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
24
1.36
0.24
1.0
2.5
mu/l
2.9
1.4
—
5
24
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
98
599
1.07
0.24
1.1
1.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
26
1.26
0.22
1.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
10
51
1.28
0.22
1.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
20
152
0.86
0.22
12.9
8.2
—
—
—
0
0
(3010422) Chicken meat IgE Ab [Units/volume] in Serum
0
7
0.00
0.22
0.0
1.1
—
0.0
—
0
7
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
27
1.21
0.22
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
89
620
0.94
0.22
1.6
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
78
546
0.93
0.22
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
250
1694
0.96
0.22
1.1
1.1
—
—
—
0
0
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
8
0.00
0.22
0.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
293
1851
1.03
0.21
1.1
1.1
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
67
470
0.93
0.20
1.6
1.6
umol/l
2.1
2.0
0.50
61
438
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
14
76
1.20
0.20
1.1
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
297
1879
1.03
0.20
1.3
1.2
nmol/l
0.6
1.5
0.67
290
1804
(3032868) Hemoglobin electrophoresis panel in Blood
13
70
1.21
0.20
1.5
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
45
269
1.09
0.19
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
401
2551
1.03
0.19
3.7
3.4
mg/l
24.5
22.4
0.55
225
1605
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
90
622
0.94
0.18
1.1
1.1
u/ml
55.8
9.1
—
6
51
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
106
729
0.95
0.18
1.4
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
93
575
1.06
0.18
2.6
2.1
e6/l
480.2
509.5
0.14
77
482
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
13
71
1.20
0.18
1.5
1.3
ml/s/173m2
1.0
1.5
—
7
38
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
28
164
1.12
0.17
2.4
2.4
u/field
0.5
0.8
1.36
28
164
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
4345
28199
1.01
0.17
2.2
2.3
mg/l
3.0
2.9
1.58
3662
24166
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
139
870
1.04
0.17
1.2
1.3
mmol/l
2.3
2.1
0.56
126
806
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
44
1.19
0.17
2.4
4.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
18
134
0.88
0.16
1.1
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
32
229
0.91
0.16
1.1
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
47
1.11
0.16
1.1
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
50
0.78
0.16
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
99
678
0.95
0.16
1.1
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
9
50
1.18
0.16
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
921
6098
0.99
0.15
3.7
3.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
9
53
1.11
0.15
1.2
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
44
267
1.08
0.15
3.9
2.5
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
7
56
0.82
0.15
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
99
618
1.05
0.14
1.3
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
43
261
1.08
0.14
1.1
1.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
27
160
1.10
0.14
4.0
5.6
%
76.0
69.4
0.60
19
122
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
64
442
0.95
0.14
2.1
2.1
ug/min
23.9
35.8
0.35
12
77
(3006245) CD3-CD19+ cells/100 cells in Blood
44
308
0.93
0.14
1.5
1.9
%
12.9
8.8
1.09
37
290
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
290
1851
1.02
0.13
1.2
1.2
u/ml
2.6
3.6
0.87
79
614
(3004446) Plasmodium sp identified in Blood by Light microscopy
16
118
0.89
0.13
2.4
2.3
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
23
136
1.10
0.13
1.1
1.3
mmol/l
5.8
5.6
—
9
68
(3005011) Chlamydia sp Ab [Titer] in Serum
28
199
0.92
0.13
1.8
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
51
314
1.06
0.12
1.7
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
28
168
1.09
0.12
1.4
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
17
124
0.90
0.12
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
115
725
1.04
0.12
1.1
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
45
312
0.94
0.12
1.0
1.2
pmol/l
202.4
336.7
3.31
33
226
(3029075) Extractable nuclear Ab panel - Serum
63
392
1.05
0.11
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
279
1786
1.02
0.11
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
18
130
0.90
0.11
1.1
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
66
451
0.96
0.11
1.1
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
36
220
1.07
0.11
1.8
2.6
mmol/l
6.1
7.1
2.15
20
132
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
49
303
1.06
0.11
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
294
1884
1.02
0.11
1.3
1.2
nmol/l
0.2
0.3
1.38
19
109
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1041
6863
0.99
0.10
2.4
2.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
62
424
0.95
0.10
1.1
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
56
1.17
0.10
1.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
30
210
0.93
0.10
5.6
5.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
33
202
1.07
0.10
1.1
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
30
1.09
0.10
36.4
12.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
58
396
0.96
0.09
2.3
2.2
umol/l
46.5
54.3
1.33
45
307
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
5
31
1.05
0.09
1.4
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
115
730
1.03
0.09
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
251
1610
1.02
0.09
1.3
1.3
pmol/l
376.9
291.2
0.35
205
1261
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
6
35
1.12
0.09
3.3
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
20
120
1.09
0.09
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
25
152
1.07
0.08
1.8
2.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
278
1787
1.02
0.08
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
262
1739
0.98
0.08
1.4
1.5
mu/l
55.7
52.7
0.11
232
1565
(3009677) Dengue virus Ab [Presence] in Serum
7
43
1.06
0.08
1.4
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
41
281
0.95
0.08
1.2
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
46
314
0.96
0.08
1.3
1.4
%
42.6
41.9
0.04
31
215
(3010937) Rubella virus Ab [Presence] in Serum
6
48
0.82
0.08
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
74
468
1.03
0.07
1.7
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
9
54
1.09
0.07
1.2
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
126
805
1.02
0.07
1.1
1.1
ratio
1.0
1.1
2.21
75
274
(3018851) Theophylline [Moles/volume] in Serum or Plasma
16
96
1.09
0.06
1.7
1.8
umol/l
51.2
47.6
0.11
16
96
(3028679) Herpes simplex virus Ab [Presence] in Serum
86
547
1.03
0.06
1.2
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
92
616
0.98
0.06
1.4
1.6
nmol/l
3.0
3.3
0.08
80
499
(3014765) Yersinia sp identified in Stool by Organism specific culture
575
3724
1.01
0.06
1.2
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
44
299
0.96
0.06
1.5
1.8
%
27.4
26.3
0.20
39
286
(3006922) Hepatitis E virus Ab [Presence] in Serum
121
806
0.98
0.06
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
51
322
1.03
0.05
2.4
2.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
569
3688
1.01
0.05
1.2
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
99
633
1.02
0.05
1.5
1.9
%
110.4
101.6
1.61
88
576
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
65
435
0.98
0.04
1.1
1.1
—
—
—
0
0
(4268621)
185
1194
1.01
0.04
2.3
2.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
574
3728
1.01
0.04
1.2
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
86
553
1.02
0.03
2.7
2.1
e9/l
0.2
0.2
0.02
75
478
(3041806) Other cells [#/volume] in Blood by Manual count
17
117
0.95
0.03
1.4
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
10
60
1.09
0.03
1.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
38
255
0.97
0.02
2.1
1.6
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
39
249
1.02
0.02
1.2
1.1
%
88.4
95.8
—
7
53
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
12
74
1.06
0.01
1.6
1.2
ug/l
78.5
124.8
—
6
47
(3000034) Microalbumin [Mass/volume] in Urine
164
1066
1.00
0.01
2.5
2.8
mg/l
22.1
35.9
0.81
111
701
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
25
159
1.03
0.01
1.2
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
329
2144
1.00
0.00
1.3
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
36
239
0.98
0.00
1.1
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
37
243
0.99
0.00
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
14
93
0.98
0.00
1.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
10
64
1.02
0.00
1.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
17
112
0.99
0.00
1.0
1.1
nmol/l
14.5
11.9
—
6
26
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
64
418
1.00
0.00
4.7
4.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
26
171
0.99
0.00
11.1
8.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
38
251
0.99
0.00
1.2
1.1
%
75.2
79.1
—
5
51
(3000285) Sodium [Moles/volume] in Blood
24
154
1.02
0.00
1.3
1.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
25
162
1.01
0.00
1.1
1.5
nmol/l
975006.9
295391.5
0.45
16
130
(3020650) Glucose [Presence] in Urine
47
306
1.00
0.00
1.3
1.6
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012403) Metanephrines [Moles/time] in 24 hour Urine
5
32
1.02
0.00
1.0
1.2
—
21.1
—
0
6
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
5
37
0.88
0.00
1.0
1.2
—
—
—
0
0
(3016072) Theophylline [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
48
0.95
0.00
1.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
36
0.91
0.00
1.0
1.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017830) Gliadin IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
5
35
0.93
0.00
1.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
6
43
0.91
0.00
2.7
2.3
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027114) Cholesterol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_BREAST_EXALLC – Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)
GWS hits: 90
This endpoint is excluded (different definition than used in FinnGen).